Colorectal cancer: a comparative study of models of health care delivery in two adjacent trusts in South Wales by Shah, Parin Rajendra
  
Colorectal Cancer:  
A Comparative Study of Models of Health Care 
Delivery in Two Adjacent Trusts in South Wales 
 
 
 
Parin Rajendra Shah 
 
 
A Submission presented in fulfilment of the 
requirements of the University of Glamorgan / Prifysgol 
Morgannwg for the degree of Master of Philosophy 
 
 
 
January 2009 
i 
Declaration  
Statement 1 
This thesis is the result of my own investigation, except where otherwise stated.  
Other sources are acknowledged by giving explicit references.  
 
Candidate  ………………………………………… 
Date   ………………………………………… 
 
 
Statement 2 
This work has not previously been accepted in substance for any degree and is 
not being submitted in candidature for any degree at any other University, 
other than the degree of M Phil of the University of Glamorgan. 
 
Candidate  ………………………………………… 
Supervisor  …………………………………………    
 
 
Statement 3 
I hereby give consent for my thesis, if accepted, to be available for 
photocopying and for inter-library loan and for the title and summary to be 
made available to outside organisations. 
 
Candidate   …………………………………………  
Date    .………………………………………... 
 
ii 
Acknowledgements 
I would like to thank the colorectal units of both hospitals for giving me access 
to their databases to conduct this study. This research project was possible due 
to the wholehearted support of Prof. P. N. Haray, consultant colorectal 
surgeon, North Glamorgan NHS Trust, who initiated the project and provided 
guidance and motivation to see it through. I am also grateful to him for the 
time and effort spent out of hours for editing and correcting this dissertation. I 
would like to thank Prof. M. E. Foster, consultant colorectal surgeon, 
Pontypridd and Rhondda NHS Trust, for his advice and constant moral 
support throughout the project. 
 
I am also thankful to Prof. D. Cohen, Professor of Health Economics, University 
of Glamorgan who, as the Director of Studies, gave me guidance, support and 
was especially patient while I was writing up my thesis.  
 
My special thanks to Fasih Alam, Research Fellow at the University of 
Glamorgan not only for providing me with statistical support for this project 
but also improving my knowledge of SPSS ®. 
 
I would like to record my gratitude for the support from various audit staff in 
locating and collecting case notes. My special thanks to Ms. Lisa Wells and 
Mrs. Pam Green, colorectal department secretaries at Prince Charles Hospital 
who have provided me with help and support.   
 
I am thankful to my wife, Priti for her time and patience whilst I spent time to 
do this project. I am also grateful to my sons Avaneesh (Athrv) and Adhit for 
keeping my stress levels low! 
 
iii 
Abstract  
Introduction 
Survival in colorectal cancer patients is dependant on the stage of the cancer at 
diagnosis.    Referral via an appropriate pathway to a specialist service is vital 
to the early detection of colorectal cancer but there is neither a standard referral 
system nor a nationally agreed referral pathway in the UK. Though studies 
have compared individual components of different models of health care in 
colorectal cancer, this is the first study comparing two models in their entirety.   
Hypothesis 
The distinct model of service delivery in Trust A picks up a higher percentage 
of early colorectal cancers than the model of service delivery in Trust B.  
Method 
The study compares colorectal cancers diagnosed from two adjacent Trusts in 
Wales during a three year period. The samples obtained after rigid exclusions 
correlate the two models of health care with the stage of cancer at diagnosis. 
Results  
Trust A has a higher emergency and urgent workload. The overall pick up of 
early cancers is similar in both Trusts.  However, there is a higher pick up rate 
of early colorectal cancer in Trust A, when GPs accessed the specialist service 
using an urgent referral through the elective route. Trust A had lower overall 
waiting times for the first clinic appointment but there was no difference for 
urgent cases between the two Trusts.  Specialists in Trust B had a higher rate of 
re-prioritisation of urgent GP referrals to the non urgent category. 
Conclusion 
There appears to be no significant difference in the overall pick-up rate of 
modified Dukes’ A colorectal cancers between the two models of health care 
delivery. The higher pick up rate of early colorectal cancer in Trust A was 
achieved only where GPs sent patients into the specialist service using an 
urgent referral through the elective route. 
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Definitions 
 
Colorectal Cancers: 
All tumours originating from the mucosa of the colon or rectum and described 
histologically as an adenocarcinoma. 
 
Colon cancers: 
All tumours fitting the above criteria originating in any part of the colon and 
classified according to the specific site as follows:  
Caecum, ascending colon, transverse colon, descending colon and sigmoid 
colon. 
 
Rectal cancers[1]:  
Any tumour where the lower margin of the tumour is within 15 cm of anal 
verge as defined by the consultant in the patient case notes, as per the 
definition from the Association of Coloproctology of Great Britain and Ireland 
[1]. 
 
Elective route of access:  
Any patient referred to and seen in the outpatient services which include 
special colorectal clinic (RACRC), general outpatient clinics and open access 
nurse led flexible sigmoidoscopy service. These referrals may have originated 
xii 
from general practitioners (letters or designated forms) or Inter-departmental 
(from specialties other than colorectal surgery).   
 
The elective route of access has been further sub-divided into urgent and non-
urgent categories (Flow diagram 1). 
 
Urgent referral:  
Any referral deemed to be urgent by a general practitioner (GP) or by a 
specialist colorectal consultant.  These may include GP referrals via the 
designated colorectal referral forms appropriately annotated as urgent 
referrals, referrals by general practitioners using a letter and inter-
departmental referrals from hospital consultants  other than colorectal 
specialists (Flow diagram 1). 
 
Non – urgent referral:  
Any referral not prioritised as urgent in the designated forms and all referrals 
from any source prioritised as non-urgent by the specialist colorectal 
consultants (Flow diagram 1). 
 
Emergency routes of access:  
Any patient seen by the colorectal team on a non-elective basis. These could 
originate through the Accident and Emergency Department or from general 
xiii 
practitioners admitting acutely unwell patients as emergencies or by other 
consultant colleagues requesting an immediate consultation for their in-
patients (Flow diagram 1). 
 
Modified Dukes’ staging (based on histological examination of the resection 
specimen after operation).  
This is accepted as one of the standard pathological staging processes for 
colorectal cancer [1, 2]. 
 
A Invasive adenocarcinoma not breaching the muscularis propria   
B Invasive carcinoma breaching the muscularis propria, but not involving 
regional lymph nodes 
C1 Invasive carcinoma involving regional lymph nodes (apical node 
negative) 
C2 Invasive carcinoma involving regional lymph nodes (apical node 
positive) 
D Presence of distant metastases (now accepted as  Dukes’ D, though not 
described in the original modified Dukes’ staging) 
 
 
 
 
xiv 
TNM staging 
This is now the accepted international standard pathological staging system  
 
T   Primary tumour 
Tx  Primary tumour cannot be assessed 
T0  No evidence of primary tumour 
T1 Tumour invades submucosa 
T2 Tumour invades muscularis propria 
T3  Tumour invades through muscularis propria into subserosa or into non-
peritonealised pericolic or perirectal tissues 
T4 Tumour perforates the visceral peritoneum or directly invades other 
organs or structures  
 
N  Regional lymph nodes 
Nx  Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastases 
N1 Metastases in 1 to 3 pericolic or perirectal lymph nodes 
N2 Metastases in 4 or more pericolic or perirectal lymph nodes 
 
M Distant metastases 
M0  No distant metastases 
M1 Distant metastases 
xv 
 
Correlation between the Dukes’ staging and TNM staging: 
 T Stage N stage M stage 
Dukes’ A T1 / T2 N0 M0 
Dukes’ B T3 / T4 N0 M0 
Dukes’ C Any T N1 / N2 M0 
Dukes’ D Any T Any N M1 
 
Dukes’ A (early cancer) correspondence to colorectal cancer localised within 
the bowel with no nodal spread and absence of distant metastases. 
 
Curative resection: 
This was defined as removal of the primary tumour in patients with no 
evidence of distant metastases, in which there was no macroscopic or 
microscopic evidence of residual disease either locally or at distant sites on 
histological examination. 
 
Rapid access colorectal clinic / Fast track colorectal clinics: 
These are specialist clinics, which are designed to assess patients who are 
referred with high-risk symptoms with suspicion of colorectal cancer. 
 
 
xvi 
One stop clinic / Rapid access colorectal clinic with flexible sigmoidoscopy: 
These are specialist clinics as defined above with the facility to perform 
immediate flexible sigmoidoscopy (endoscopic examination of the rectum and 
distal colon) during the same visit.  
 
Open access flexible sigmoidoscopy clinic: 
These are specialist clinics to which general practitioners directly refer patients 
with symptoms of rectal bleeding for flexible sigmoidoscopy. Once the 
procedure is performed patients are referred back to the general practitioners 
or referred to other specialists for opinion or further management. These 
services can be Doctor (consultant) led or Nurse led. 
 
Nurse led flexible sigmoidoscopy clinic: 
These are services provided by specially trained nurses who perform flexible 
sigmoidoscopy independently and can be accessed directly by general 
practitioners without a referral to a specialist colorectal consultant. 
 
Trusts 
Trusts are organisations responsible for managing and/or delivering health 
services. There are a variety of Trusts, the two most common being Primary 
Care Trusts (PCTs) and NHS Trusts. PCTs are local organisations responsible 
for managing health services in a given local area. A PCT in Wales is referred 
xvii 
to as a Local Health Board (LHB). NHS Trusts manage hospitals, but can also 
provide services in the community [3]. 
 
Access mechanisms of referral in the models of health care delivery in 
present study: 
Flow diagram 1 illustrates the access mechanisms for patients with colorectal 
cancer in the models of health care delivery being discussed in this study.  
xviii 
Access mechanisms of referral in the models of health care delivery in this 
study (Flow diagram 1) 
 
Patients referred by GPs to both Trusts  
 
Trust A – North Glamorgan NHS Trust  
Trust B – Pontypridd and Rhondda NHS Trust 
 
Elective routes of access 
 
Emergency routes of access 
 
All referrals via emergency routes are by 
definition urgent and seen on the same day 
 
Various emergency categories 
1. Accident and emergency 
2. GP emergency  
3. Inter-departmental  
 
Various elective categories 
1. GP 
2. Inter-departmental 
Inter-departmental GP 
Referral via both these categories could be either 
urgent or non-urgent 
 
Sub-category of GP referral  
1. RACRC (Trust A only) 
2. General outpatient clinic 
(Both the Trusts) 
3. OAFS (Trust B only) 
 1 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
Introduction 
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1.1 General introduction 
Survival in colorectal cancer patients is dependant on the stage of the cancer at 
diagnosis.    Referral via an appropriate pathway to a specialist service is vital 
to the early detection of colorectal cancer.  It is clear from the literature that 
there is neither a standard referral system nor a nationally agreed referral 
pathway in the UK to assess these patients. This thesis will attempt to evaluate 
two different models of service provision with regard to the diagnosis for 
patients suspected to have colorectal cancer. Such a study comparing the 
effectiveness of models in their entirety, one incorporating a rapid access 
colorectal clinic with flexible sigmoidoscopy as one of its components and the 
other, with a general surgical outpatient clinic has not been undertaken 
previously.    
 
1.2 Aim 
The aim of this thesis is to compare the clinical effectiveness of these two 
models of service delivery in South Wales with specific regard to the diagnosis, 
for patients suspected to have colorectal cancer.  
 
1.3 Specific objectives 
a) To identify different characteristics of models of care for the diagnosis of 
colorectal cancer across the UK as published in the literature. 
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b) To highlight these characteristics specifically in the North Glamorgan NHS 
Trust (Trust A) and the Pontypridd and Rhondda NHS Trust (Trust B) 
included in this study. 
c) To compare the impact of these two different models of service on the 
tumour stage at diagnosis. 
d) To correlate stages of cancer at diagnosis with the deprivation levels.  
 
1.4 Hypothesis 
The model of service delivery in Trust A picks up a higher percentage of early 
colorectal cancers (modified Dukes’ A) than the model of service delivery in 
Trust B.  
 
1.5 Chapters 
Chapter 2 will provide the background to this study with specific reference to 
the aims and objectives set out above.  It will discuss the referral systems in the 
two participating Trusts and describe the prioritization of referral letters from 
general practitioners prior to the first outpatient appointment. It will also 
highlight the high-risk criteria used. Finally, it will discuss the key differences 
in the two Trusts.  
 
Chapter 3, the literature review, will concentrate on the current status of the 
diagnosis of colorectal cancer in the UK along with the referral models by 
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which urgent and non-urgent patients are assessed in various types of clinics. It 
will discuss the stage of cancer and delays in diagnosis with respect to the 
guidelines and standards laid down by the Department of Health. 
 
Chapter 4 will explain the methods used to perform this study. It will describe 
the type of study, define the sample and specify the inclusion and exclusion 
criteria.  It will also highlight issues around data protection, its sources, and the 
methodology of data analysis. 
 
Chapter 5 is the results chapter and is divided into 4 sections. The first section 
discusses the overall cancers diagnosed in the two Trusts, the sample and the 
reasons for exclusion. It also compares the demographics of the sample with 
the Welsh data. It then compares the demographics of the samples from each of 
the two Trusts. The second section presents and analyses the results of the 
different routes of access and the waiting times for these different routes for the 
patients in the study.  The third section presents the anatomical location of the 
cancers diagnosed in the study population in relation to their stage at diagnosis 
and routes of access to the specialist services and also correlates the 
deprivation levels of the population with the stage of cancer at diagnosis.  
Finally, the fourth section summarises the significant results of the present 
study.  
 
 5 
Chapter 6 entitled ‘Discussion’, reviews the results of this study from each of 
the result sections above, in the light of available literature and published 
studies internationally, in the UK and from these Two Trusts. It will also briefly 
discuss the potential cost implications of these models of health care delivery. 
 
Chapter 7 will present the conclusions drawn from this study.  
 
 Chapter 8 will discuss the possible future research and recommendation from 
this study. 
 
 
 6 
 
 
 
 
 
 
 
 
 
Chapter 2 
Background 
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2.1 Incidence, survival and mortality of colorectal cancer 
Colorectal cancer is one of the most common malignant conditions with an 
annual incidence of approximately 35,000 cases per year (1, 4) and is the second 
most frequent cause of cancer death in the UK. Although, there have been 
many advances in diagnosis and treatment modalities in recent years, there has 
been only a moderate improvement in the survival (5). Survival from bowel 
cancer in the UK is worse than the USA or Europe owing to presentation of 
patients with advanced disease (6, 7). The death rate from colorectal cancer in 
Wales is amongst the highest in the United Kingdom (3). It is higher for colon 
cancer than rectal cancers. The mortality for colon cancers in 2000 was 26.2 
(crude rate per 100,000) for men and 21.8 (crude rate per 100,000) and that for 
rectal cancers was 10.7 (crude rate per 100,000) for men and 7.7 (crude rate per 
100,000) for women (3). Approximately 25% of patients in the UK and other 
countries present with locally advanced or metastatic disease (6-8).  
 
2.2 Stage of colorectal cancer and survival 
The system used for staging of colorectal cancer is the one described by 
Cuthbert Dukes in 1930 and later modified by Astler and Coller (1954). 
According to this system, modified Dukes’ A denotes an early cancer.  The 
TNM classification (as described in section on ‘definitions’) is currently 
accepted as a standard method of evaluating disease extent.  Early colorectal 
cancer stage (Dukes’ A) correspondence to T1 or T2 cancers with no nodal 
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disease and absence of distant metastases. Accurate pathological staging of the 
disease can be done only post-operatively and this informs the decision for any 
further adjuvant oncological treatment.  Survival in colorectal cancer depends 
predominantly on the stage of the tumour at diagnosis, though there are 
several other less significant factors (9-11). Patients with Dukes’ stage A 
(T1/T2,N0,M0) have a much better 5-year survival of over 80% as compared to 
those with Dukes’ stage D  (Any T, any N, M1) which is approximately 3% (1). 
 
The current guidelines published by the Association of Coloproctology of 
Great Britain and Ireland (ACPGBI) place great emphasis on reducing the 
duration from presentation of symptoms to specialist assessment (4).  This can 
be achieved by models care encompassing early referral, designated referral 
pathways and clear investigative and management protocols. 
 
2.3 Early referral  
In order to improve service provisions for colorectal cancer, it is important for 
patients to identify symptoms early and for general practitioners and hospital 
clinicians to be aware of guidelines.  In the UK, 25 – 33% of colorectal patients 
present as an emergency admission with large bowel obstruction or other 
symptoms. The average general practitioner is likely to encounter one such 
patient every three years (3).  These patients have poorer outcome than patients 
who present electively, along with high cancer-related and inter-current death 
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rates (12). A study published form Italy which looked at colorectal cancers 
diagnosed over 14 years highlighted that a patient’s level of education  
regarding symptoms of colorectal cancer, the increased use of colonoscopy and 
a greater attention to symptoms were all significant factors in improving 
survival in colorectal cancers and resulted in an increase in the detection of 
localised (Dukes’ A or T1/T2, N0, M0) colorectal cancers (13).   
 
Symptoms relating to intestinal problems are very common which means that 
identifying the few patients who will turn out to have bowel cancer can be 
difficult. The ACPGBI guidelines for general practitioners aim to identify 
patients with a high risk of colorectal cancer. These referral guidelines facilitate 
referral of high-risk patients to specialist clinics for their assessment as per the 
Department of Health’s Two-week standard (6, 14).  
 
Early diagnosis demands health care delivery with clearly defined reliable 
referral pathways for patients suspected to have colorectal cancer, so that they 
can be prioritised and fast tracked to specialist services (1).   
 
2.4 Screening  
A significant survival advantage and diagnosis of early cancer can be achieved 
by screening asymptomatic populations (15). This has been demonstrated 
convincingly in cervical and breast cancers in the UK (16-18) and in colorectal 
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cancer in the USA (17). The national bowel cancer-screening programme is at 
present being set up in the UK and will achieve nation wide coverage by 2009 
(19).  The results of the pilot programme showed that nearly 48% of these 
screen detected cancer were modified Dukes’ A (19).  Initial results from a 
multicentre Medical Research Council (MRC) trial of screening with flexible 
sigmoidoscopy of people aged 55-65, followed by colonoscopy in those 
considered to be at high risk showed that cancers were found in 0.3% of those 
screened, 74% of which were Dukes’ stage A or stage B, and adenomas were 
detected in 12% (3). 
 
2.5 Stage at diagnosis   
 The pick up rate for modified Dukes’ A cancers in outpatient clinics in the UK 
varies between 9 to 15% (20) with very little change over the last 20 years(21, 
22), in spite of the introduction of the “Two Week Standard”. The variability in 
the pick up rate may be related to the overall model of care provided rather 
than the individual clinicians concerned.  
 
Specialist clinics with flexible sigmoidoscopy have reported a 23% pick up rate 
of with Dukes’ A cancer (23) and those without flexible sigmoidoscopy have 
been shown to be less efficacious in this regard (24). Open access nurse led 
flexible sigmoidoscopy clinics alone have better patient acceptability but cancer 
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yield is poor when compared with doctor led service (one stop clinic).  They 
also appear to have little impact on the utilisation of radiological resources (25).  
 
The importance of diagnosis of colorectal cancers at an early stage is further 
discussed in detail in the review of literature.  
 
2.6 Trusts 
There are two Trusts in South East Wales covering a population of 330,000 
providing secondary care service to Merthyr and Rhondda – Cynon – Taff 
valleys, Trust A (The North Glamorgan NHS Trust) and Trust B (The 
Pontypridd and Rhondda NHS Trust).  Since this work was undertaken the 
two Trusts have merged (April 1, 2008) to form the Cwm Taf NHS Trust. 
 
Trust A: The North Glamorgan NHS Trust 
The North Glamorgan NHS Trust was established in April 1996 to provide 
acute, community and mental health services to the people in the Merthyr, 
Cynon and upper Rhymney valleys in South Wales. The Trust's catchment 
population is approximately 150,000.  
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Trust B: The Pontypridd and Rhondda NHS Trust 
Serving a population of 180,000, The Pontypridd and Rhondda NHS was 
established in April 1999 and aims to meet the physical and mental health care 
needs of the people in Rhondda Cynon Taff and Taff Ely.  
 
These two Trusts have similar distributions of general population with respect 
to gender, age distribution and socio-economic status (26); however in one 
Trust all patients are assessed in general outpatient clinics with support from a 
nurse led flexible sigmoidoscopy service. The neighbouring Trust has a rapid 
access colorectal clinic with a flexible sigmoidoscopy service, where most of the 
patients are assessed.  This is in addition to general outpatient clinics.  
 
 These two different models of service delivery may lead to differences in the 
stage at which colorectal cancers are diagnosed.  Such a comparative study has 
not been undertaken previously. The detailed access mechanism to specialist 
services is discussed in 2.7. 
 
2.7 Routes of access to specialist services 
As seen from flow diagram 2, the primary mode of elective colorectal referrals 
to the specialist units in both Trusts is through outpatient clinics. In Trust A, 
designated rapid access colorectal clinics (with flexible sigmoidoscopy) as well 
as general outpatient clinics are used to assess patients with suspected 
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colorectal cancers. In Trust B, patients are seen in general outpatient clinics. In 
addition, there is an open access nurse-led flexible sigmoidoscopy service, 
which is also used to diagnose cancers.  
 
Both Trusts also receive emergency referrals to the specialist units from 
Accident & Emergency and other departments within the hospital (flow 
diagram 3 and 4). 
 
There is a further variation in the referral systems of the two Trusts. In Trust A, 
there is a special designated referral form (Appendix I), which is used by 
general practitioners to refer patients with colorectal symptoms. Its unique 
design allows classification by general practitioners of these referrals as urgent 
and non-urgent. A tick mark in the box at the top right hand corner would 
prioritise the referral as an urgent case, which results in the patient being 
appointed to the clinic within 14 calendar days. In addition to this referral 
route, GP letters are also received by Trust A (flow diagram 3), which need 
prioritisation by the specialists.  
 
As seen from flow diagram 4, in Trust B, if a patient is referred via the 
designated referral form then it is not re-prioritised. Although the designated 
form is available in Trust B, it is not the preferred mode of referral by general 
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practitioners (personal communications) and hence the consultants in Trust B 
have to prioritise most of the referral letters received. 
 
2.8 Development of RACRC in Trust A 
The RACRC was established in Trust A in 1997 as a part of colorectal sub 
specialisation along with a multi-disciplinary team.  Initially, the referral 
criteria were very general.  However, a designated referral form was structured 
and disseminated to the general practitioners in 2000.  This was based on a 
local audit to assess the sensitivity and specificity of the new high risk referral 
criteria from the ACPGBI (modified ACPGBI criteria as described in 2.10). 
Once the patients were reviewed in the RACRC, a strict criterion of rectal 
bleeding with age above 50 years was used to select patients for immediate on-
site flexible sigmoidoscopy which was performed under consultant 
supervision (23). An initial audit highlighted cancer pick up rate of 23% from 
this services (23).  
 
2.9 Development of OAFS in Trust B 
A nurse led open access flexible sigmoidoscopy service was introduced in 1996 
in Trust B after a senior endoscopy nurse practitioner was trained in 
accordance with approved guidelines. This service utilised minimal referral 
criteria (age > 45 years and fresh rectal bleeding). The acceptance of this clinic  
by general practitioners in the first year itself was 41% (25, 27, 28). A nurse 
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endoscopist role was developed to support the general outpatient clinics  in 
assessing patients referred with rectal bleeding (personal communication). 
However, a previous study from Trust B has shown a low cancer yield with 
OAFS (25). 
 
2.10 High-risk colorectal symptoms for an urgent referral  
Only patients with new and persistent symptoms listed below should be 
referred to the fast-track system as per the guidelines from the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI).   These criteria are as 
follows: 
 
1. Rectal bleeding WITH a change in bowel habit to increased frequency of 
defecation and/or looser stools and persistent for at least 6 weeks – All ages 
2. Rectal bleeding persistently without anal symptoms – over 60 years 
3. Change in bowel habits to increased frequency of defecation and /or looser 
stools persistent for at least 6 weeks – over 60 years 
4. Patients with an easily palpable right iliac fossa mass 
5. Patients with an easily palpable intraluminal rectal mass 
6. Patients with an unexplained iron deficiency anaemia: 
a. Haemoglobin below 11g/dl in men – All ages 
b. Haemoglobin below 10g/dl in women – post-menopausal 
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A previous study carried out in Trust A (29), however showed that these 
criteria lacked sensitivity. This study reviewed 50 consecutive colorectal 
cancers diagnosed in 2000. According to the above criteria, 82% of these cancer 
patients would have been suitable for referral to the rapid access colorectal 
clinics. However, 18% of the cancers would have been missed, as they would 
not have been eligible for referral if these criteria had been applied. The 
authors recommended modifying the criteria, which increased the sensitivity 
to 94% (29).  
 
Therefore, these criteria were modified as follows and have been used 
successfully in both Trusts. These modified criteria are: 
1 Rectal bleeding with change in bowel habits (CIBH)  – 6 weeks (all ages) 
2 CIBH without rectal bleeding – 6 weeks (>50 yrs) 
3 Rectal bleeding without anal symptoms (> 50 yrs) 
4 A definite palpable abdominal mass (all ages) 
5 A definite palpable rectal mass 
6 Iron deficiency anaemia  
7 Abdominal pain and weight loss 
Both the Trusts have a policy of re-prioritising referral letters. Re-prioritisation 
of these referrals can either upgrade them to urgent or downgrade to non-
 17 
urgent. However, both Trusts do not re-prioritise referrals sent in on the 
designated forms.   
 
All patients suspected with colorectal cancer (prioritised urgent letters and 
urgent designated forms) are expected to be seen within 14 calendar days of 
the GP referral in both the Trusts, as per the Department of Health regulations.  
 
After initial assessment in the outpatient clinics, urgent investigations are 
arranged for patients suspected to have colorectal cancers. This process has 
inherent delays as seen in the flow diagram 1 from the time of referral from 
general practitioners to the diagnosis and staging of patients with colorectal 
cancers as shown below: 
 
1. The time from referral from GP to 1st clinic appointment. 
2. The time from receipt of referral in the Trust to the first out-patient 
appointment. 
3. Time of the consultants for prioritisation of referrals by the GP. 
4. The time first seen by specialist (consultant) to the date of the definitive 
diagnostic test. 
5. The time from confirmation of diagnosis to completion of staging. 
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Multidisciplinary meetings (MDM) are an inherent part of all cancer services in 
the UK. They are composed of the surgical teams led by consultant colorectal 
surgeons, consultant radiologists, consultant pathologists, consultant 
oncologists, colorectal specialist nurses, and the palliative care team. All the 
colorectal cancers diagnosed are discussed in the MDM initially to assess pre-
operative staging and formulate a treatment plan.  The cases are discussed 
again to review the post-operative histology and plan further treatment and 
follow up. In both Trusts, colorectal cancers are discussed on a weekly basis 
and dealt with through the respective MDMs.   
 
After definitive diagnosis, all patients have staging investigation to establish 
the stage of the disease and rule out distant metastases. After staging, patients 
are subjected to treatment, either curative or palliative (surgery or radiotherapy 
or chemotherapy or a combination of treatment). These aspects are beyond the 
scope of the present study. 
 
2.11 Key differences in the referral systems in the two Trusts 
1. Trust A has a designated rapid access colorectal clinic (RACRC) with 
flexible sigmoidoscopy. (This does not exist in Trust B). 
2. Trust B has an open access flexible sigmoidoscopy clinic (OAFS) run by a 
nurse specialist. (This does not exist in Trust A). 
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3. In Trust B, all patients referred to the specialist are assessed in general 
outpatient clinics. In Trust A, patients are assessed in RACRC. In addition, 
general outpatient clinics are used for assessment of any patients who have 
not been referred using the designated rapid access referral forms.  
4. All patients referred via emergency routes of access are either assessed in 
the accident and emergency department or on the ward as in-patient if 
referred from other departments. This is similar in both the Trusts. 
5. There are designated forms available in both Trusts. Whenever the 
designated forms are used, re-prioritisation by a specialist consultant is not 
required. (The use of these forms by general practitioners to refer patients 
varies in both the Trusts). 
6. Both the Trusts receive a variable number of referrals via hand written or 
typed general practitioners’ (GP) letters. All these are re-prioritised by 
specialist consultants. 
7. Patients are also referred from non colorectal hospital consultants. These 
can be referred via either the elective routes of access and seen in the clinics 
or emergency as described earlier as in-patients. All these referrals via the 
elective routes of access are re-prioritised 
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Referral pathway in the two Trusts (Flow diagram 2) 
Patients referred by GPs to both Trusts 
 
 
        Variations in routes of access in the two Trusts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients suspected of colorectal cancer are further investigated, 
Trust A 
North Glamorgan 
NHS Trust 
  
    
  
  
 
Trust B 
Pontypridd and 
Rhondda NHS Trust 
Principal routes of access (see also flowchart 
A) 
1. Rapid access colorectal clinics (RACRC) 
2. General outpatients clinics: typed and 
hand written GP referral letters* 
3. A & E referrals 
4. Inter-department referrals 
Principal routes of access (see also flowchart B) 
1. General outpatient clinics: typed and hand 
written letters* 
2. Open access nurse-led flexible 
sigmoidoscopy (OAFS) 
3. A & E referrals 
4. Inter-department referrals  
 
All patients referred to RACRC are prioritised 
via designated referral forms and are seen in 
RACRC. 
All the patients are seen by colorectal surgical 
team and either investigated or discharged. 
All patients referred to OAFS are first seen 
during endoscopy. If sigmoidoscopy is 
abnormal, patients are then referred to a 
consultant and investigated. (The patients with 
the normal sigmoidoscopy are discharged back 
to the GP and are not seen by the consultants. 
*The method of prioritisation in general outpatient clinics is similar in both the Trusts. 
All GP referral letters are prioritised as urgent or non-urgent by the consultant and urgent referrals (patients 
suspected of having colorectal cancer) are seen in the clinic as soon as possible 
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Patients referred by GPs to Trust A (Flow diagram 3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trust A 
North Glamorgan NHS Trust 
A & E referrals and Inter-
departmental referrals 
Designated pink referral 
forms 
All forms marked urgent by 
GPs are booked in clinic and 
seen within 14 calendar 
days. No prioritisation by 
consultants is required. 
After receipt of all letters, they 
are sent to consultants for 
prioritisation. All marked as 
urgent (suspected of colorectal 
cancer) are seen within 14 days 
in clinics 
Hand written or typed 
letters 
A & E referrals are seen and 
admitted in the hospital. These 
are all urgent admissions and   
investigated. (No clinic 
waiting period). 
Inter-departmental referrals 
are seen either as in-patient 
(same day if referred as an 
urgent referral) or in the 
outpatient clinic (non-urgent 
referrals). 
All patients suspected of colorectal cancer are further investigated and managed.  
General Outpatients Clinics 
Rapid Access Colorectal 
Referrals (RACRC) 
The clinic also has the 
facility to provide on site 
flexible sigmoidoscopy 
when necessary. 
 22 
Patients referred by GPs to Trust B (Flow diagram 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trust B 
Pontypridd & Rhondda NHS Trust 
A & E referrals and Inter-
departmental referrals 
Hand written or typed 
letters 
Designated referral forms 
exists but not used 
frequently by referring GPs  
 
After receipt of all 
letters/forms, they are sent 
to consultants for 
prioritisation. All marked as 
urgent (suspected of 
colorectal cancer) are seen 
within 14 days in clinics 
 
Open Access Nurse-led 
Flexible Sigmoidoscopy 
(OAFS) 
Referral by GP for flexible 
sigmoidoscopy (history of 
bleeding PR and age > 45 
years) 
A & E referrals are seen and 
admitted in the hospital. These 
are all urgent admissions and   
investigated. (No clinic 
waiting period). 
Inter-departmental referrals 
are seen either as in-patient 
(same day if referred as an 
urgent referral) or in the 
outpatient clinic (non-urgent 
referrals). 
All patients suspected of colorectal cancer are further investigated and managed.  
All patient with normal 
sigmoidoscopy are referred 
back to GP, whereas those 
with abnormality are seen by 
the consultants in General 
Outpatient Clinics 
General Outpatient Clinics 
No RACRC exists 
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2.12 Research problem 
Survival in colorectal cancer patients is dependant on the stage of the cancer at 
diagnosis.    Referral via an appropriate pathway to a specialist service is key to 
the early detection of colorectal cancer. It will be clear from the review of 
literature that there is neither a standard referral system nor a nationally 
agreed referral pathway in the UK to assess these patients. This thesis will 
attempt to evaluate two different models of service provision with regard to 
the diagnosis for patients suspected to have colorectal cancer.   A previous 
study by Arumugam et al compared RACRC in Trust A with OAFS with Trust 
B (25). However, these were only components of the two models of health care 
delivery.  A study comparing the effectiveness of entire models on the pick up 
rate of early cancer, one with a rapid access colorectal clinic incorporating 
immediate flexible sigmoidoscopy, as one of its components, and the other, a 
general surgical outpatient clinic, has not been undertaken previously. 
Hospitals/ Trusts in the UK use a combination of routes of referral which make 
each one virtually unique.  Most commonly, patients are seen in either general 
outpatient clinics or rapid access colorectal clinics (one stop access) with 
different referral pathways, forming different models of service delivery.  A 
comparison between some of these different models in their entirety may help 
delineate systems with better diagnosis rates for early cancers.  
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This study is based on the hypothesis that the model of health care delivery in 
Trust A has a better pick up rate of early stage colorectal cancers as compared 
to the model in Trust B.  
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Chapter 3 
 
Review of literature 
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3.1 Scope of literature review 
Given the aims of this research project, the review of the literature will 
concentrate on the current practices in the diagnosis of colorectal cancer in the 
United Kingdom and the models of health care delivery (including the various 
types of clinics and referral pathways etc.), by which patients suspected of 
colorectal cancer are being assessed. This study is mainly concerned with 
different referral pathways. The literature review will exclude studies 
concerned with the screening of asymptomatic patients for colorectal cancer as 
well as the various aspects of investigation, treatments (operative or radio-
chemotherapy) or follow up.  
 
The review will begin by highlighting the prevalence and incidence of 
colorectal cancer in the UK, as well as the stage of cancer and survival data in 
the UK along with guidelines and standards laid down by the government to 
improve the detection of early cancer.  It will then discuss the main issue of the 
referral systems in the UK and attempt to discuss published studies on various 
types of outpatient services. Finally, it will stress on reasons for delays in 
diagnosis of colorectal cancer and factors impacting on the stage of the cancer 
at diagnosis. 
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3.2 Literature review method 
A review of literature was performed using Medline, Ovid and Cochrane 
databases in the English language publications relating to colorectal referrals 
and staging. The keywords used to search the databases were colorectal cancer, 
rapid access clinic, one stop clinic, referral, stage, early cancer, prioritisation, 
open access flexible sigmoidoscopy, waiting times, delays, two week standard 
and Dukes’ A. Although there was no date restriction on the studies 
considered, only those studies with references published on search databases 
were considered for the review.  
 
3.3 Colorectal cancer in the UK 
In the UK, about 35,000 people are diagnosed with bowel cancer every year 
with little change in the national 5-year mortality rate of 40% over the past 
many years.  In England and Wales, colorectal cancer is the second commonest 
cause of cancer related death in the UK after lung cancer in terms of both 
incidence and mortality (1, 3, 4). The incidence of colorectal cancers in England 
and Wales is 52.85 per 100,000 and mean age of presentation is 71 years. In the 
UK, male incidence rates have increased by an average of 1% each year for the 
last 20 years, but in women, the rates have changed very little (30).   
 
In Wales, colorectal cancer is the second most common cancer in males and the 
third most common cancer (after breast and lung) in women. In the 5-year 
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period 1986-1990, there was an average of 870 new registrations per annum for 
colorectal cancer in both men and women, which was higher than any of the 
other regions (30, 31).  
 
Survival from bowel cancer in the UK is poorer than in Europe, perhaps 
because approximately one quarter of the UK patients are diagnosed with 
incurable disease or have delayed treatment (6, 7, 30, 32). A study by Gatta et al 
looked at the 5-year survival for the colorectal cancer across Europe. In Europe, 
only Netherlands, Sweden, Switzerland and France had 5-year survival greater 
than 50% in both sexes. This was compared with the available data from US, 
Japan and Australia where it was between 50 – 60% (32).  The death rate from 
colorectal cancer in Wales is amongst the highest in the UK (3). The mortality 
for colon cancers in 2000 was 26.2 (crude rate per 100,000) for men and 21.8 
(crude rate per 100,000) and that for rectal cancers was 10.7 (crude rate per 
100,000) for men and 7.7 for women (crude rate per 100,000) (3). 
 
3.4 Stage of colorectal cancer and survival 
Tumour stage at diagnosis is one the most important prognostic factors for 
survival of patients with colorectal cancer along with vascular invasion and 
tumour ploidy (33). Several studies have shown that survival in colorectal 
cancer is directly related to the stage at diagnosis (1, 30, 34). Data from the 
Birmingham registry between 1977 and 1981 indicated that, after curative 
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resection the 5 year-age-adjusted survival for colon cancer was 85%, 67% and 
37% for Dukes’ A, B and C cancers stage (1). Other factors include the number 
and location of affected lymph nodes (10)  and presence of hepatic metastases 
(11).Wrigley et al have shown that socio-economic factors and cultural 
differences also play a significant role in survival after colorectal cancer (9). The 
reasons for these, however, are not clear (3).   There have been improvements 
in the 5-year survival from colorectal cancer over the last 25 years for both 
colon and rectal cancer in both the sexes. This is due to earlier diagnosis and 
better treatment; nevertheless, the overall picture in the UK is still 
disappointing (30). As mentioned in 3.3, the poor survival in the UK as 
compared to the rest of the Europe relates to late presentation or delay in 
treatment (30).  
 
Patients diagnosed and treated at an early stage have a better 5–year survival 
as compared to those with advanced disease (35). Approximately 25% of 
patients in the UK and other countries present with locally advanced or 
metastatic disease (6-8).  A study from Rome by Barillari et al divided the 
patients diagnosed with colorectal cancer in groups according to the duration 
of symptoms. Their study showed that asymptomatic patients appeared to 
present with less advanced disease (higher incidence of T1N0M0) and thus had 
better survival  (36). Interestingly, the study also highlighted that the duration 
of intestinal symptoms did not appear to be related to the stage and prognosis 
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of tumours (36), as the other groups with symptoms varying from < 3 months 
to more than a year had no correlation between the site of cancer or the stage. 
A study by Kiran et al also showed no significant difference in Dukes' staging 
in patients with symptoms lasting less or more than 6 months (37). Adams et al 
showed that if elderly patients survived their operation, they had a better 
prognosis than younger patients (38, 39). Patients aged < 40 years have a 
poorer prognosis as they are usually diagnosed with advanced disease (40-42). 
However, a literature review performed by O’Connell et al showed that if 
young people are diagnosed early (Dukes’ A or B), they have a better 5-year 
survival (43). People with colorectal cancer tend to develop non-specific 
symptoms leading to emergency presentation with advanced disease (3). These 
patients are also associated with high post-operative mortality and a poor 5–
year survival (12).  A study by Scott et al highlighted that (44) 5-year survival 
rate was lower for colorectal cancer presenting as emergency  when compared 
to elective presentations (29% versus 39 %). 
 
3.5 Guidelines 
Guidelines for the management of colorectal cancer have been published by the 
Association of Coloproctology of Great Britain and Ireland (ACPGBI) in co-
operation with the British Society of Gastroenterology  (BSG) and the Royal 
College of General Practitioners (1).  The guidelines state that “the high incidence 
of this disease, together with the fact that improvement in mortality in recent years has 
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been modest, highlights the need for research into prevention, earlier diagnosis and 
better treatment” (1, 4). In the absence of clearly defined screening protocols, the 
path to earlier diagnosis clearly involves the time from presentation to 
specialist assessment being as short as possible.   
 
Questions have been raised regarding the sensitivity (accuracy of diagnosing 
colorectal cancer) and specificity (accuracy of ruling out colorectal cancer) of 
the referral guidelines published by ACPGBI and the Royal College of 
Surgeons and modifications have been suggested to make the guidelines more 
effective (29, 45). The ACPGBI referrals criteria have sensitivity between 80 – 90 
%, which can be increased to over 90% by bringing down cut off age to 50 years 
instead of 60 years (29).  
 
3.6 Early referral 
A high percentage of colorectal cancers present as emergency admissions  (6-8).  
Waldron et al looked at the presentation in patients aged less and greater than 
70 years and found that older patients > 70 years are more likely to present as 
emergencies (58% versus 41%) (46). A study from a district general hospital by 
Scott et al also confirmed a high incidence (30%) of colorectal cancers 
presenting as an emergency admission (44). These patients have more 
advanced tumours (Dukes stage B and C, 96% versus 88% of those admitted 
electively). The mortality (19 versus 8 %) was higher in the emergency group. 
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They had shorter history but longer stay in the hospital (median stay 16 versus 
13 days).  Hence, these patients require far greater resource provision from the 
hospital and the community (44).  Cancer patients presenting as emergency 
presentation are less well and may have complications of the disease as 
presenting symptoms e.g. intestinal perforation or obstruction (44).  Avoidance 
of emergency presentation by pre-emptive detection and conversion to elective 
care would be a rational solution to this problem (44).   
 
A referral made to a non–surgical specialty can significantly delay diagnosis of 
cancer. This has been recognised with lung cancer. A study by Billing et al 
raised concerns that respiratory physicians spent on an average 109 days prior 
to referral to surgeons (47). Similarly in the Wessex audit on the colorectal 
cancer, initial referral to physicians led to significant longer delay to treatment 
(1). 
 
3.7 Wessex and Trent/ Wales audit 
An audit of colorectal cancer management was conducted in the Trent and 
Wales regions in 1992-1993 and another prospective audit was conducted in 
Wessex from 1991 to 1994. Both these audits looked at the management of 
colorectal cancer patients including referral, diagnosis, clinical management 
and follow up. These audits highlighted that 65% of the delay in patients 
having elective surgery for rectal and sigmoid cancer occurred before referral 
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to a hospital and 20% during the process of diagnosis and treatment. These 
audits also highlighted the fact that there was a 15% delay from referral to 
patients being actually seen at specialist clinics (5). There was a longer time to 
treatment for patients primarily referred to physicians in comparison with 
those referred to surgeons (1). They also raised concern that the time to referral, 
diagnosis and treatment had not changed for the preceding twenty years. 
However, the delay in the waiting time for an outpatient appointment could be 
affected by introduction of the government’s ”Two Week” standard (1).  
 
3.8 “Two Week” standard 
In an attempt to improve the healthcare services for cancer patients, the 
Department of Health introduced the “Two Week Rule” with effect from 1st 
July 2000.  According to this rule ‘everyone with suspected cancer will be able to see 
a specialist within two weeks of their GP deciding that they need to be seen urgently 
and requesting an appointment’ (6, 14). This has led to changes in the practices of 
various surgeons and Trusts across the country (48) to reduce the waiting times 
from referral to the specialist clinic (14, 49).  However, no steps have been 
taken to counteract the delay prior to referral to a specialist, which has been 
shown to be significant (5, 20) as highlighted by Trent/Wales and Wessex 
audits.  
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A study from Canada looking at the delay in the management of cancers has 
also shown that the delay has mainly been from referral to treatment which 
was 29 days rather than first clinics appointment which was only 11 days (50). 
This was due to shortage of operating room time, lack of other resources such 
as diagnostic tests or preference of allied health personnel and circumstance of 
the patient.   A similar delay after the outpatient referral to diagnosis has been 
shown in the Trent/Wales and Wessex audits and by a study from the 
Porstmouth (1, 20). In view of this, the government has recently added 
additional targets of 62 days for the time between referral by general 
practitioners to the commencement of the first definitive treatment, and also of 
31 days for the time between diagnosis (decision to treat) to the initiation of 
treatment (51). However, this literature review has not concentrated on this 
area, as this is beyond the scope of this study. 
 
Over the past two years, numerous studies have raised questions regarding the 
appropriate working of the ‘Two Week Rule’. This rule necessarily relies on the 
appropriateness of the referrals (20).  A patient referred urgently on the basis of 
ACPGBI criteria will be fast tracked through the system and will be seen 
within two weeks. However, if the system is clogged with unnecessary  or 
inappropriately marked urgent referrals then this may in turn prolong waiting 
times for non-urgent referrals (52) .  
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3.9 Routes of access to specialist colorectal services 
There are predominately two routes of access: elective and emergency.  
 
3.9.1 Elective route of access 
The elective route is for those patients who have colorectal symptoms and are 
referred to outpatient diagnostic services such as RACRC, general outpatient 
clinic, OAFS etc. This route is predominantly used by general practitioners but 
also used by consultants from other specialities who have patients with 
colorectal symptoms. 
 
There are three traditional routes of access for general practitioners as defined 
by ACPGBI, which are based on the colorectal referral criteria (1) for elective 
referrals:  
1) Fast track clinics (Two-week standard) – for higher risk criteria e.g. 
rectal bleeding or change in bowel habits persisting for more than six 
weeks as described in the Background. 
2) Urgent appointment in general outpatient clinic – persistent low risk 
symptoms but with other worrying factors such as positive family 
history.  
3) Non-urgent appointment in general outpatient clinic – for patients 
with low risk symptoms who do not qualify as an urgent referral.  
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The two Trusts included in this study have similar routes of referral in place 
but there is an overlap. Trust A, as defined earlier, has a RACRC and at the 
same time urgent and non-urgent referrals are seen in the general outpatient 
clinics.  In Trust B, the majority of referrals are seen in the general outpatient 
clinics as urgent or non-urgent, but in addition there is a nurse-led flexible 
sigmoidoscopy service. 
 
3.9.2 Emergency routes of access 
The emergency routes of access are predominately used by general 
practitioners when faced with acutely unwell patients who need immediate 
hospitalisation. This route is also used by patients who self present at accident 
and emergency departments as well as by hospital specialists other than 
colorectal surgeons who may have inpatients requiring emergency colorectal 
care. 
 
3.10 Types of outpatient clinics in the UK 
An extensive literature search has identified 3 types of clinics in which patients 
are being assessed.  
1. One stop clinic / rapid access colorectal clinic with or without flexible 
sigmoidoscopy service 
2. Open access flexible sigmoidoscopy service 
 37 
3. General outpatient clinics (no facility for immediate flexible 
sigmoidoscopy) 
 
3.11 One stop clinics 
The rapid access or fast track proctology clinic has been reported as early as 
1993 (53). In this report, it was a weekly walk in coloproctology clinic started in 
London. The review of its first year showed reduction in waiting times,  
improved patients’ and general practitioners’ satisfaction and raised awareness 
of colorectal disease.  The first one stop or open access clinic was developed in 
the USA for patients suspected to have breast cancer with the facility of 
mammography at the same time as the first clinical examination (54). Since 
then, there are increasing examples of such clinics in the UK, involving a whole 
range of surgical and non-surgical specialities (55-59).  
  
In recent years, rapid access or one stop colorectal clinics have become the gold 
standard in colorectal departments. These clinics offer immediate flexible 
sigmoidoscopy where the facilities are available (3, 23, 24, 49, 60). Specialist 
colorectal clinics e.g. fast track or rapid access are demonstrating earlier 
diagnosis with shorter waiting times (23, 61, 62). A study by Jones et al showed 
that one stop clinics had better acceptance even if carried out in the evening. 
This pilot clinic led to reduction in waiting time for flexible sigmoidoscopy 
from 119 to 63 days. Once this pilot project ended, the waiting list went back 
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up again to 108 (62). Davies et al have shown that fast track services reduce 
emergency admission to hospitals (63). The results of this study showed a 
similar trend; however, the difference did not achieve statistical significance   
(p = 0.06).  
 
Studies on RACRC have shown that these clinics are associated with a higher 
cancer detection rate and short waiting times for specialist assessment (48). 
Chohan et al highlighted that fast track clinics (RACRC) have sped up the 
process of assessment of patients suspected to have colorectal cancer with 
better (14%) cancer yield (64). These types of services have also been shown to 
have better patient satisfaction (49). Overall, these clinics have led to improved 
clinical effectiveness with variable pick up rates of colorectal cancer between 
1.7% to 14% (3, 23, 48, 49, 64).  
 
Walsh et al have shown that the “Two Week Standard” has reduced clinic 
waiting times, but may not have had a major impact on patient outcomes; as 
there were no time limits for investigations or treatments (14). A review by 
Carter et al in 1993 suggested that the diagnostic delay at hospital level had 
increased from one week to six weeks (65). There has been evidence that this 
delay between the time patients are seen at clinic and the time that treatment 
begins has not been affected by the two week rule (14, 20). Potter et al showed 
that the average diagnostic delay may be more than one month (66), as also 
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shown by other studies (64). A study from Canada highlights that although 
there is median wait of 11 days from referral to first visit, the time from first 
visit to treatment is only 20 days (50). This issue is being addressed in the 
revised National Cancer Standard where targets have been set for diagnostic 
and treatment times as well as referrals times (51). Accordingly, there is now a 
31 day standard for the commencement of treatment from date of  diagnosis of 
cancer, and an overall target of 62 days from the date of urgent referral from 
general practitioners to the start of  treatment.  
 
The two-week standard had been used as a safety net by general practitioners 
to refer patients to specialist clinics. This has led to controversies on the 
effectiveness on the current referral system caused predominantly by a large 
number of inappropriate referrals flooding rapid access clinics (48). At least 
half of those referred as urgent cases do not fit the national guidelines (3). Some 
general practitioners do not follow the national guidelines correctly, as a result 
of which 18% of cancer patients were found to have been sent as non urgent in 
a report by the Commission for Health Improvement / Audit Commission (3). 
 
Questions have been raised on the utilisation of these services as a large 
number of cancer patients are still sent to hospitals by other routes of access 
(67). 26% of the cancers diagnosed in the study by Barrett et al presented as 
emergency admissions of this 10% were admitted after being seen in the fast 
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track clinic.  The percentage of cancers diagnosed by routes other than clinics 
has been reported as high as  75% (68).  
 
3.12 Open access flexible sigmoidoscopy clinic  
Open access flexible sigmoidoscopy was reported for the first time in Northern 
Israel (69). There were 225 patients referred for flexible sigmoidoscopy during 
the first year. Adenomatous polyps or colorectal cancers were detected in 27% 
of these referrals. Their cancer yield was 11.4% which was better than their pick 
up rates from barium enema examinations. A study by MacKenzie et al 
compared open access endoscopy service to consultant led outpatient clinics. 
There was a significant trend for patients in the consultant led service to have 
more investigations leading to more cost per patient. There was no difference 
in the time taken to diagnose cancer in the two groups.  This study further 
recommended referral to open access endoscopy service for colonoscopy or 
flexible sigmoidoscopy so that patients could have their investigations at one 
hospital attendance (70). Open access endoscopy services have illustrated their 
effectiveness when compared to consultant-led clinic in terms of diagnosing 
colorectal cancers or requesting other large bowel investigations (70). 
 
A similar study from both the Trusts participating in the current study has 
shown that though open access endoscopy  services may help in reducing the 
delay in diagnosing colorectal cancer, they appear to have little impact on stage 
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of cancer at diagnosis (25, 71).  In 1994, a study showed that nurses can carry 
out screening flexible sigmoidoscopy as accurately and safely as experienced 
gastroenterologists (72). Nurse endoscopist have been widely used in the USA 
and Australia for screening colorectal cancer (72-74).  In the UK, there has been 
a role expansion of nurses as endoscopists over the past decade (28, 75-77).   
 
Open access nurse led flexible sigmoidoscopy services have not been shown to 
be cost effective and do not lead to a reduction in the numbers of other 
diagnostic tests such as barium enema being performed (71). This study by 
Vellacott et al demonstrated that this service does lead to a decrease in the 
number of outpatient visits for patients. This study did not support the 
proposition that direct access flexible service should be made nationally 
available; however, its recommendation was that if facilities were already 
available, then it may have some benefit for both patients and general 
practitioners (71).  Another study from Australia has supported that nurse led 
clinics have been shown to be clinically effective along with better patient 
satisfaction (74).  Jain et al suggested that although nurse led diagnostic 
services have not been shown to be cost effective, this may be a cost effective 
way for screening colorectal cancer in an asymptomatic population (78).  
 
In summary, open access clinics (doctor led or nurse led) have been found to be 
superior to conventional consultant led clinics; reducing waiting times for 
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consultation (49, 70). In addition, they appear to be more accessible, with better 
acceptability in comparison to conventional consultant led outpatients clinics  
(49).  
 
3.13 General surgical outpatient clinics 
This is a standard form of clinic routinely used to assess patients. With wider 
use of rapid access clinics for urgent and cancer referrals, these clinics are 
increasingly being used for non-urgent and potentially benign referrals.  These 
clinics have a low pick up rate of cancers due to nature of referrals e.g. 2.2% 
(20).  The waiting times for the first clinic appointment in these clinics vary 
significantly (61, 64); from 44 days for an urgent referral to 1 year for a non-
colorectal benign referral to a specialist colorectal unit (79), though with the 
recent government targets reducing waiting times for all referrals, this is likely 
to reduce (51).  To counteract this problem of long waiting periods, “paper 
clinics” have been established in various hospitals, in which the case notes with 
requested investigations are reviewed by consultants and a plan is derived. 
This actually decreases unnecessary follow up appointments (68, 80). 
 
3.14 Prioritisation 
There are various mechanisms across the UK for triaging urgent and non-
urgent referrals. The standard mode of referral is a letter from a general 
practitioner (81), which goes through the process of prioritisation by specialist 
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consultants and is marked as urgent or non-urgent based on ACPGBI 
guidelines. This process has inherent delays as well as difficulties in accurate 
prioritisation due to incomplete information in the referrals letters. A previous 
study by Basnyat et al  has shown that referral letters from general practitioners 
often do not contain enough relevant information to allow for appropriate 
prioritisation by hospital consultants (27). In an attempt to solve this problem, 
some units have developed a designated referral form based on ACPGBI high 
risk criteria for colorectal cancer (23, 25). This allows general practitioners to 
prioritise patients to be seen urgently in specialist clinics e.g. rapid access rectal 
bleeding or colorectal clinics with or without immediate flexible 
sigmoidoscopy (23) . 
 
In a similar manner, a surgical unit at Crewe has developed a scoring system 
based on the number of symptoms and symptom complexes to produce a 
computer generated numerical score. This scoring system helps to identify 
patients with a high likelihood of colonic cancer (82).  
 
For emergency referrals, the process of prioritisation is absent as these are 
acutely unwell patients being referred via one of the emergency routes of 
access e.g. accident and emergency, emergency admission to the hospital via 
GP etc.  
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3.15 Delays to diagnosis 
A major factor that contributes to the low incidence of early cancers is the delay 
that can occur at three different levels: the patient, the general practitioner and 
the hospital (65); the longest delay possibly being between the time that the 
patient notices symptoms and his/her presentation to the general practitioner.  
Holliday et al in 1979 highlighted that the mean delay from onset of symptoms 
to diagnosis for colonic cancer was 30.5 weeks and that of rectal cancer was 38 
weeks (83). Similarly, delay in the presentation of rectal cancer has been found 
in other studies (84).  Most of these delays occurred outside the hospital, 
attributed to patients and family doctors. There has been no change in “help 
seeking” for the symptoms for colorectal cancer in the last l5 years (85).  Nearly 
50% of the delay is due to patients’ ignorance of their symptoms. In one study, 
nearly 90% of patients discussed their symptoms with relatives but only 22% 
approached a physician (65). A study in Italy has shown that patients’ level of 
knowledge and awareness of colorectal symptoms may have an influence on 
whether they seek professional help early  (13). 
 
General practitioners who examine their patients do refer them early to 
specialists (86). A study of 500 consecutive patients showed that half did not 
have rectal examination by the general practitioner and 31% had no 
examination at all. Amongst those examined, the diagnosis was incorrect in 
half of them (87). Further delays on the part of general practitioners could be 
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due to failure to perform recto-sigmoidoscopy / proctoscopy or even digital 
rectal examination (88). 
 
One of the causes of delay in diagnosis at the hospital could be the result of 
inappropriate referrals by general practitioners, referring patients with 
significant colorectal symptoms as a non-urgent referrals or referring patients  
to a non-surgical speciality (65). The delays at the hospital can also be due to 
mis-diagnosis by a GP. Hence, prioritisation of these referrals is important (27).  
 
The other cause of delay at the hospital could be due to referrals to other 
departments (66), diagnostic delay and administrative delay. According to 
Potter et al 34% of patients, have to wait more than one month due to these 
reasons. A study comparing the duration involved in the management 
pathway for patients diagnosed with colorectal cancer in 1998 and 2003 
showed that there is an increase in the number of patients being referred as 
urgent to specialists in 2003 as compared to 1998. However, the proportion of 
patients receiving treatment within 31 days of diagnosis or 62 days of urgent 
referral has not changed in these 5 years (89).  
 
There is no correlation between the duration of history and stage of tumour at 
diagnosis (37, 90, 91).  Emergency presentation is associated with shorter 
history and more advanced disease (44) along with a higher  mortality (92). 
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3.16 Staging  
Clinical outcome, including survival following treatment of colorectal cancer, is 
affected by the local extent of the disease, lymph nodes status and the presence 
of metastases (1). One of most commonly systems used for staging of colorectal 
cancer is the one described by Cuthbert Dukes’ (1930) and later modified by 
Astler and Coller (1954). This staging system describes stage A when the 
tumour is confined to the bowel wall, stage B when the bowel wall has been 
breached, stage C when lymph nodes are involved and stage D when there are 
distant metastases (1, 2). In recent years, TNM staging has become the standard 
system and the correlation between these two systems has been outlined in the 
Definitions. Patients with early disease (modified Dukes’ A, T1/T2,N0,M0)  
 
Komuta et al have shown that early stage of cancers is more common in 
asymptomatic patients and can be identified only by screening (15, 17, 93). A 
study published from Nottingham looked at the stage migration of colorectal 
cancers over a period of 10 years after the introduction of haemoccult 
screening.  This study was divided as pre 1989 and post 1989. It highlighted 
that changing awareness of colorectal cancer and its symptomatology amongst 
patients and general practitioners led  to  significantly increased proportion of 
Dukes’ A cancers diagnosed (94). This was especially true for rectosigmoid (9.9 
% to 28%) cancer but not for colonic cancers (10.9% to 11.5%).  
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The national bowel cancer-screening programme is at present being set up in 
the UK and will achieve nation wide coverage by 2009 (19).  The results of the 
pilot programme showed that nearly 48% of these screen detected cancer were 
Dukes’ A (19).  A multicentre UK trial of screening with flexible sigmoidoscopy 
of people aged 55-65, followed by colonoscopy in those considered to be at 
high risk, picked up cancers in 0.3% of those screened, 74% of which were 
Dukes’ stage A or stage B, and adenomas were detected in 12% (3). However, 
the effect of the screening on the stage of cancer at diagnosis is beyond the 
scope of this study. 
 
In the Trent/ Wales audit, Dukes’ A cancer accounted for only 10% of all the 
colorectal cancers diagnosed. A study by Flashman et al has shown that the 
pick up rate of patients with Dukes’ A cancers in the general outpatient clinics 
and specialist clinics varies between 9 to 15% (20). Studies from other countries 
like New Zealand and Italy have also shown proportions of patients diagnosed 
with Dukes’ A cancer to be 4 – 18 % (95, 96). Miller et al compared the 
colorectal cancer data from different periods between 1969 – 1976 and 1989 – 
1995. This study showed the resectability of cancers increased, stay in hospital 
and 30 day mortality declined. Despite apparent earlier presentation and 
improved surgical resectability, the proportion of patients with localised 
disease (Dukes' stage A and B) had not changed significantly (21). Another 
study from the UK performed in 1995 compared data available between 1966 – 
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1971 and 1979 – 1983. There was no difference in the Dukes’ staging of 
colorectal cancer in the study groups (22). Similarly, there has been no change 
in the proportion of patients diagnosed with early cancer in 20 years in 
Australia and also in the UK (21, 22). It is difficult to pick up early cancer 
without screening. It is also a problem in countries such as China where 
analysis of over 2000 patients showed a very low incidence of Dukes’ A cancer 
(97).  
 
Specialist clinics with flexible sigmoidoscopy have reported a significant 
improvement in the proportion of patients diagnosed with Dukes’ A cancer 
from 11% to 23% after sub-specialisation in surgical speciality (23). 
 
Specialist clinics without flexible sigmoidoscopy are considered to be unsafe 
(24) and have shown to be less efficacious in identifying Dukes’ A cancers and 
the pick up rate appears to be similar to other clinics (45, 49). Open access 
nurse led flexible sigmoidoscopy clinics alone have better patient acceptability 
but cancer yield is poor when compared with doctor led services (one stop 
clinic). At the same time, they also seem to have little impact on the utilisation 
of radiological resources (25). However, in this study, the RACRC and the 
OAFS are not strictly comparable, as the doctor led service (RACRC) used the 
ACPGBI guidelines and was set up specifically to diagnose cancers and the 
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nurse led (OAFS) service was an evaluation service for patients with rectal 
bleeding.   
 
Cancer patients referred via fast track clinics are seen more quickly than those 
sent via standard modes of referral.  However, these patients sometimes 
appear to present with more advanced disease, raising a question again 
regarding the appropriateness and prioritisation of these referrals from  
primary care(64).  A study by Trickett et al showed that patients referred by 
general practitioners to allied medical specialities or the emergency department 
present with advanced disease while those referred to either fast track clinics or 
general outpatient clinics (urgent or non-urgent) have early disease (98). 
However, this study did not differentiate between urgent and non-urgent 
referral.  A study by Lamah et al did not show any difference in stage 
distribution of colorectal cancer diagnosed through the different modes of 
referrals (49). 
 
This review of the literature has not revealed any study correlating different 
types of the referral with its categories (urgent and non-urgent) on the stage of 
tumour at diagnosis nor has it revealed any comparisons between models of 
care in their entirety. 
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3.17 Summary of review 
From the literature review, it is evident that colorectal cancer is a major health 
concern in the UK. Even in the presence of clearly defined guidelines from 
ACPGBI and standards from the Department of Health, the pick up rate of 
early cancers (Dukes’ A) still remains low throughout the UK.  This is due to 
the fact that referral practices vary widely throughout the UK with no standard 
model.  
 
One-stop open access clinics have already been shown to be more accessible, 
acceptable and more effective than conventional consultant led general 
outpatient clinics.  Inspite of these differences, many health care delivery 
service models are unable to incorporate one stop clinics, probably due to lack 
of resources. Studies so far, have not compared the impact of prioritisation and 
modes of referrals on the stage of cancer at diagnosis. There is no evidence of a 
systematic nationally accepted protocol to assess urgent referrals.  
 
Individual components of models of health care delivery have varied effects on 
the diagnosis and management of patients suspected of colorectal cancer. The 
cumulative effect these components could be beneficial or detrimental, but has 
not been studied before. The present study compares two different models of 
health care delivery in two adjacent Trusts in South Wales, with regards to the 
stage at diagnosis.  The next chapter with discuss the methods of this study.  
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Chapter 4 
Methodology 
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4.1 Introduction 
This chapter explains the methods used in this study.   
 
4.2 Study design 
This is a retrospective study performed using secondary data (i.e. data that had 
already been recorded). The sample in this study consisted of patients 
diagnosed with colorectal cancer in the two adjacent Trusts in South Wales.  
These patients were selected based on inclusion and exclusion criteria 
mentioned below. 
 
4.3 Inclusion criteria 
All patients diagnosed with colorectal cancers between 1st January 2001 and 
31st December 2003 were eligible for inclusion.   
 
4.4 Exclusion criteria 
1. All patients who were deemed unsuitable for surgery due to severe co-
morbidities were excluded.  These included only those patients where 
either staging was not performed, or if staging was carried out, it did not 
reveal distant metastases. These patients were excluded because, without a 
resection specimen in these cases, staging information was not available.  If 
any of these patients who were excluded due to severe co-morbidity, were 
found to have metastatic disease, they were included as Dukes’ D.  
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2. All patients diagnosed to have cancer within a polyp treated only with 
endoscopic resection  
3. Patients found to have cancer in an appendicectomy specimen. 
4. Patients referred to the consultant surgeons as private patients, as they were 
not referred via the referral system within the National Health Service. (All 
these patients bypassed the system for their first specialist appointment.) 
 
4.5 Study groups 
The patients selected belonged to either of two study groups based on the 
hospital at which they received treatment;   
Trust A: The North Glamorgan NHS Trust 
Trust B: The Pontypridd and Rhondda NHS Trust 
 
4.6 Identification of colorectal cancer patients 
Patients included were identified from the colorectal cancer databases at each 
Trust.  All patient details were further cross-checked and re-confirmed with 
multidisciplinary meeting (MDM) records, surgical department patient data, 
and finally re-confirmed with the cancer services co-coordinators’ data for 
completeness in each Trust. 
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4.7 Sample representativeness  
Representativeness is the extent to which the sample of a study compares with 
a wider population.  It is evident from literature that the mean age of incidence 
of colorectal cancer in scientific published papers could not be directly 
compared with the present sample. This could be due to studies from different 
geographical locations or lack of adequate demographic detail in some of the 
published studies (32, 99) . It could be also due to studies involving a particular 
site of colorectal cancer e.g. sigmoid colon or rectum (100).   The Welsh Cancer 
Intelligence and Surveillance Unit collates data for all colorectal cancers 
diagnosed in Wales.  Comparison with this data would better indicate 
representativeness of the study sample.   However, the study sample is derived 
using rigorous inclusion and exclusion criteria, whereas the Welsh data 
includes all patients with a diagnosis of colorectal cancer.   
 
The present study compares differences between two distinct service models of 
the heath care delivery in adjacent geographical locations and therefore the 
study sample does not need to reflect the demographics of the general Welsh 
population.  Results, therefore, relate specifically to patients who meet the 
criteria for inclusion in this study. 
 
This study has, therefore, not attempted to fully assess representativeness of 
the sample with the general population, but has compared the data from the 
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two participating Trusts to establish demographic similarities.  The main 
measures of comparison that have been used are the mean age and gender 
distribution.   
 
4.8 Outcome measures 
In this study the primary outcome is the stage of colorectal cancer at the time of 
diagnosis.   
 
4.9 Sample size  
As this is a retrospective observational study, the sample size is fixed (the 
number of cancers diagnosed during the period). The findings of this study, 
however, can provide evidence to inform a larger and more representative 
multi-centre prospective study. Such a definitive study would perform an 
initial power calculation to determine the sample size needed to detect a 
clinically important difference in the primary outcome of a given magnitude at 
a pre-determined significance level.  
 
4.10 Data collection 
Data collection for this study has two components: 
1. Patient level clinico-pathological data from a review of patients’ records 
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2. Organisational level data regarding the structures of the two models of 
health care delivery collated from discussions with both sets of clinicians 
and managers involved as well as by direct observation 
 
4.11 Data sources 
Data used for analysis in this study were collected from following areas in each 
Trust: 
1. Colorectal cancer database 
2. Pathology records 
3. Multi-disciplinary meeting records 
4. Patients’ case notes 
5. Medical records department 
6. Human resources department 
7. Surgical Directorate Management 
8. National Public Health Service for Wales, Wales Statistics 
(www.wales.gov.uk) for deprivation  levels 
 
4.12 Clinico-pathological data 
Clinico-pathological data were collected under following headings:  
1. Patient demographics - from patients’ records (case notes). 
2. General Practitioners’ details - from patient records (case notes). 
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3. Clinic Details- from referral letters to the consultant surgeons.  
4. Symptomatology on presentation - from the referral letter as well as from 
the notes made at the time of the patients’ first appointment at the specialist 
clinic.  
5. Investigations carried out to confirm diagnosis and pre-operative stage of 
cancer - from formal radiological and pathological (biopsy) reports within 
the case notes and from the radiology department records. 
6. Histo-pathology with tumour stage - from formal report on each patient 
filed in the patient case notes. 
7. Operation details - from the operation note and MDM records. 
 
Details of data collection proforma are as shown in Appendix II. 
 
The data obtained were used to compare the stage of patients with colorectal 
cancer at the time of diagnosis between the two Trusts with respect to the 
modes and the priority of referral.  
 
4.13 Delays and checkpoints 
Data were also collected to highlight the various delays or check points in the 
two different models of health care delivery.   Time intervals between the 
various steps in the referral pathway were identified as follows: 
1. waiting period from referral from GP to 1st clinic appointment 
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2. waiting period from referral received in the Trust to 1st specialist outpatient 
appointment 
3. waiting period from 1st appointment to the date of the definitive diagnostic 
test 
4. Time from confirmation of diagnosis to final staging  
 
4.14 Townsend Index 
The Townsend index provides a material measure of deprivation & 
disadvantage.  It is a composite score based on four different variables (101). 
1. Unemployment as a percentage of those who are economically active 
2. Non-car ownership, as a percentage of all households 
3. Non-home ownership as a percentage of all households 
4. Household overcrowding 
The five Townsend Index categories are Most Affluent, Next Affluent, Median, 
Next Deprived and Most Deprived. The higher the Townsend Index score, the 
more deprived & disadvantaged an area is considered to be.  Scores can also be 
negative denoting affluent areas. If all the 9309 electoral wards of England and 
Wales were pooled and sorted in rank order according to the above criteria and 
then divided into five quintiles, than the top 20%  will represent the most 
affluent areas down to the most deprived in the bottom 20%. 
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For the population of this study, the percentage of population belonging to 
each category of the Townsend Index was obtained from the website of the 
National Public Health Service for Wales.  
 
4.15 Data protection and Caldicott guidelines 
 
Data protection regulations and Caldicott guidelines were followed to maintain 
the confidentiality of patients’ clinical data.  All patient details such as name 
and date of birth were anonymised to maintain patient confidentiality. Data 
were only used for research purposes and a master list correlating patient 
identification details was kept in a locked drawer and was accessed for data 
validation, if required. On completion of the research, the master list was 
destroyed.    
 
4.16 Ethical approval 
This study involved reviewing notes of patients who were diagnosed to have 
colorectal cancer. All colorectal cancer patients included in this study have had 
their treatment prior to the commencement of this study. The study did not 
affect the treatment or continuing care of any of the patients. The study did not 
involve patients and their identity nor did it involve patient participation.  The 
patients were not contacted at any stage of the study.  Given this and the fact 
that patient level data were anonymised meant that the study could be 
regarded as an audit.  
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The proposal was submitted to the South East Wales Local Research and Ethics 
Committee who agreed that the study could be regarded as an audit.   The 
proposal was also reviewed and approved by the Ethics Committee of the 
(then) School of Care Science, University of Glamorgan, now re-designated as 
Faculty of Health, Sports and Science, University of Glamorgan.   
 
4.17 Statistical analysis 
The clinical and pathology data were entered in to SPSS Version 11.5 for 
statistical analysis. Chi-squared tests were used for categorical data to test for 
statistical significance e.g. for stage of tumour at diagnosis in relation to 
various clinics and to compare different routes of access.  Independent t-tests 
were used for continuous data e.g. waiting times for the first clinic 
appointment.  A p value of < 0.05 was considered statistically significant. 
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Chapter 5 
Results 
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5.0.1 Introduction to results 
The results from this study have been presented in four sections. 
 
The first section deals with the cancers diagnosed in the two Trusts, the sample 
along with the reasons for exclusion. It also compares the demographics of the 
sample with the Welsh data. It then discusses the demographics of the two 
Trusts in terms of age and gender.  
 
The second section presents and analyses the results of the different routes of 
access and the waiting times for these different routes for the patients in the 
study.  
 
 The third section presents the anatomical location of the cancers diagnosed in 
the study population in relation to their stage at diagnosis and route of access 
to the specialist services 
 
Finally, the fourth section summarises the significant results of the present 
study.  
 
5.0.2 Challenges encountered in conducting this research 
The first problem was to identify all cases of colorectal cancer in the two Trusts 
and then to identify those cases eligible for inclusion in this study.  There was 
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no single source or database from which these patients could be identified in 
either of the Trusts.  Hence data were collected from various sources: MDM 
records, histopathology database, records from cancer services departments 
and operative logs. This resulted in a number of disparate lists, which required 
time to compile and eliminate duplication.  
 
In some of the cases identified from the MDM records, case notes had to be 
examined to confirm malignant pathology.  
 
The patients included in the study were being followed up not only for cancer 
follow-up with surgical teams, but also with oncologists for their further 
treatment, as well as with other specialists for concomitant illnesses. This made 
retrieval of some of case notes particularly difficult. Another problem was to 
obtain all the volumes of case notes, as old volumes had been moved to off-site 
storage areas.  
 
The presence of multiple volumes of case notes with improper filing of 
contents e. g. operation notes, histology records etc made identification of 
appropriate documents time consuming and tedious. 
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Results – section 1 
Sample demographics 
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5.1.1 Introduction 
This section presents the details of the overall cancers diagnosed in the two 
Trusts, the sample of this study and the exclusion criteria. It then discusses the 
demographics in terms of age and gender.  
 
5.1.2 The sample 
 The research sample consisted of all patients diagnosed with colorectal cancer 
in the two Trusts subject to the study’s inclusion and exclusion criteria. Details 
of data collection and validation have been described in Methodology. 
 
Table 5.1.1: Colorectal cancer included and excluded in the two Trusts  
Colorectal cancer Trust A Trust B 
Total colorectal cancers diagnosed 220 (100%) 245 (100%) 
Colorectal cancers included in this study 187 (85%) 217 (88.57%) 
Colorectal cancers excluded from this study. 33 (15%) 28 (11.43%) 
 
 
As seen from Table 5.1.1, there were 220 patients diagnosed with colorectal 
cancer identified in Trust A from 2001 to 2003. The rigorous exclusion criteria 
left only 187 patients who had full staging and were eligible for inclusion.  In 
Trust B, 245 colorectal cancers were identified in the period of which 28 were 
excluded.    
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Table 5.1.2 presents the details of patients included and excluded. There were 
no obvious differences (p = 0.25) between the two Trusts in the numbers and 
the types of cases excluded from the study.   
 
Table 5.1.2: Reasons for exclusion of colorectal cancers in Trust A & Trust B 
Reasons for exclusion Trust A Trust B 
Referred as a private patient to a specialist 7 6 
Patients with co-morbidity who were unfit for 
surgery and in whom staging was not carried outa 
10 8 
Patients with co-morbidity who were unfit for 
surgery in whom staging was carried out but did 
not show distant metastases b 
12 11 
Malignancy in polyps 2 3 
Malignancy in appendicectomy specimen 1 0 
Total 33 28 
a These patients were excluded as no staging information was available. 
b   These patients were excluded as without resection, staging information was 
not available.   
 
5.1.3 Sample representativeness 
The gender and age comparison between the study sample and the all Wales 
data  is tabulated below in 5.1.3 and 5.1.4 respectively. 
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As can be seen from the table 5.1.3 below, the male to female ratio in the study 
samples was dis-similar to that for all colorectal cancer patients in Wales.  One 
possible explanation for this is that the study included only those patients who 
met the rigid inclusion criteria whereas, the all Wales data represent all the 
colorectal cancers diagnosed, with or without staging.  
 
Table 5.1.3: Gender comparison between the sample and all Wales data (102) 
Gender Sample Trust A Sample Trust B All Wales a 
Male 121 (64.70%) 125 (57.6%) 1037 (54.32%) 
Female 66 (35.29%) 92 (42.3%) 872 (45.68%) 
Total 187 217 1909 
Male: Female 1.8 : 1.0 1.35 : 1.0 1.2 : 1.0 
a Data based on the Welsh Cancer Intelligence and Surveillance Units’ 
information 2002 
 
Table 5.1.4: Mean age comparison between the sample & all Wales data (102) 
Population under study Sample Trust A Sample Trust B All Wales a 
Sample Size 187 217 1909 
Mean age (SD) 70.97 (10.22) 68.94 (12.00) 70.05 b 
a Data based on the Welsh Cancer Intelligence and Surveillance Units’ 
information 2002  
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The mean ages from all Wales data (102) are compared to mean ages of the 
study samples in Table 5.1.4. There is no significant difference in the mean age 
of the patients in Trust A as compared to Trust B (p = 0.07). As seen from the 
table above, the mean age of the sample from Trust A is closer than the sample 
from Trust B to that of the all Wales Data.  
 
In Figure 5.1.1, the age distribution of colorectal cancers for all colorectal cancer 
patients in Wales) are presented for the year 2002.  The majority of these 
patients were in their 6th and 7th decade.   
 
Figure 5.1.1: Age distribution of colorectal cancers in Wales for the year 2002 
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The proportion of cancer patients in their 6th and 7th decade in Trust B was 
similar to that for all Wales.  However in Trust A, there was another peak 
between 60 – 65 years. 
 
5.1.4 Gender distribution 
Male to female ratio of the sample in the Trust A is 121: 66 (1.83: 1.0) and that of 
in the Trust B is 125: 92 (1.35: 1.0). There was no statistical significance in the 
distribution of male and female in these study population in the two Trusts (p 
= 0.14). 
 
 
Table 5.1.5: The distribution of sample by gender 
Gender Trust A (n = 187) Trust B (n = 217) p value 
Male 121 (64.70%) 125 (57.60%) 
0.14 
Female 66 (35.29%) 92 (42.39%) 
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5.1.5 Age distribution  
The sample distribution by age group in the two Trusts can be seen from the 
table 5.1.6 below. 
 
Table 5.1.6: Sample distribution by age group 
Age range Trust A (n = 187)  Trust B (n = 217)  
30 – 34 - - 1 0.46% 
34 – 39  - - 2 0.92% 
40 – 44  2 1.07% 4 1.84% 
45 – 49  0 0.00% 5 2.30% 
50 – 54  10 5.35% 16 7.37% 
55 – 59  13 6.95% 19 8.76% 
60 – 64  29 15.51% 20 9.22% 
65 – 69  22 11.76% 44 20.28% 
70 – 74  36 19.25% 33 15.21% 
75 – 79  36 19.25% 35 16.13% 
80 – 84  24 12.83% 19 8.76% 
85 – 90  9 4.81% 11 5.07% 
> 90 6 3.21% 8 3.69% 
Total  187  217  
 
This data is shown as histograms (Figures 5.1.2 and 5.1.3) below. 
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Figure 5.1.2:  Age distribution in Trust A  
 
Figure 5.1.3:  Age distribution in Trust B  
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The graph shows some skewness in distribution due to the fact that colorectal 
cancers naturally are more common in the older population.   
 
5.1.6 Mean age 
The mean age of the sample in the Trust A is 70.97 (SD 10.23, range 40 – 93) and 
that of the Trust B is 68.94 (SD 12.00, range 30 – 100). The difference in the 
means in the two Trusts was not statistically significant (p = 0.07) 
 
The table 5.1.7 shows the mean age as per the gender distribution in the two 
Trusts. There was no statistical significant difference (p = 0.51, independent t-
test) in males; however, the mean age of females in the Trust A was 
significantly higher (p = 0.04, independent t-test) than that of Trust B. 
 
Table 5.1.7 Comparison between mean ages of male and female in sample  
 Trust A Trust B p value 
Sample Mean age (SD) Mean age (SD)  
Male 69.63 (9.23) 68.80 (10.55) 0.51 
Female 73.43 (11.50) 69.14 (13.78) 0.04 
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Results – Section 2 
Routes of access and waiting times 
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5.2.1 Introduction 
This section presents and analyses the results of the different routes of access 
and the waiting times for these different routes for the patients in the study.    
 
5.2.2 Cancers diagnosed via elective and emergency routes of access 
As shown in Flow chart 1 (Definitions), there are primarily two routes of 
access, elective and emergency. As seen from table 5.2.1, the percentage of 
patients seen via the elective route of access in Trust B was more than Trust A.  
In contrast, the emergency workload in Trust A was higher than Trust B.  
These differences were statistically significant (p = 0.011). 
 
Table 5.2.1: Distribution of patients diagnosed with colorectal cancer as per 
routes of access 
Routes of Access Trust A Trust B p value 
Elective 101 (54%) 144 (66.35%) 
0.011 Emergency 86 (46%) 73 (33.65%) 
Total 187 217 
 
5.2.3 Cancers diagnosed via elective routes of access 
The elective routes of access were rapid access colorectal clinics, open access 
flexible sigmoidoscopy service, general outpatient clinics and inter-
departmental referrals. Table 5.2.2, shows the distribution of the cancers 
diagnosed via these defined elective routes.  
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Table 5.2.2: Distribution of cancers based on elective routes of access  
 Trust A  Trust B  
Elective Frequency Percentage Frequency Percentage 
RACRC  69 68.32% - - 
General outpatient 
clinic  
16 15.84% 101 70.14% 
OAFS - - 13 9.03% 
Inter–departmental 
referrals 
16 15.84% 30 20.83% 
Total  101  144  
 
For further sub-analysis, the above elective category has been grouped into 
inter-departmental referrals and GP referrals (RACRC, OAFS and general 
outpatient clinic).  This data is shown below in table 5.2.3. There was no 
significant difference in the distribution of the elective routes of access in the 
two Trusts (p = 0.32). 
 
Table 5.2.3: Distribution of cancers based on GP or inter-departmental 
referrals within the elective routes of access  
Elective Trust A Trust B p value 
GP referrals 85 (84.16%) 114 (79.17%) 
0.32 Inter–departmental referrals 16 (15.84%) 30 (20.83%) 
Total  101 144 
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5.2.4 Cancers diagnosed via the GP referral category within the elective 
route of access 
As seen from table 5.2.3 above, there were 85 and 114 patients in this category 
in Trust A and B respectively.  These were prioritised as urgent or non-urgent 
by the general practitioners as can be seen in Table 5.2.4 below.  
 
Analysis of this data demonstrates that general practitioners accessing the 
specialist colorectal service using the elective route, in Trust A prioritised more 
patients as ‘urgent’ and this reaches statistical significance (p = 0.03) 
 
Table 5.2.4 Prioritisation by GPs when accessing the elective route 
 
When GP referrals are received in either Trust, they can be re-prioritised by the 
specialist consultants.   
Table 5.2.5 Urgent GP referrals re-prioritised by hospital consultants 
Re-prioritisation by consultants Trust A Trust B p value 
Urgent 74 (97.36%) 75 (85.22%) 
p = 0.007 Non-urgent 2 (2.64%) 13 (14.78%) 
Total 76 88 
Prioritisation as per GP Trust A Trust B p value 
Urgent 76 (89.41%) 88 (77.19%) 
0.03 Non-urgent 9 (10.59%) 26 (22.81%) 
Total  85 114 
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As seen from the table 5.2.5, almost 97.36% (74/76) of the urgent referrals by 
the general practitioners were sent in using designated referral forms and 
therefore were seen as urgent in Trust A. The remaining 2.64% (2/76) patients 
had been sent in on referral letters rather than the designated form and were 
re-prioritised by the specialist consultants and seen as non-urgent. In Trust B, 
all GP referrals including those marked urgent were re-prioritised which led to 
85.22% (75/88) being seen as urgent and 14.78% (13/88) as non-urgent. This 
achieved statistical significance (p=0.007).   This suggests that the presence of a 
designated referral form is vital for general practitioners to refer patients 
urgently to the specialist consultants. 
 
Table 5.2.6 Non-urgent GP referrals re-prioritised by hospital consultants 
Re-prioritisation by consultants Trust A Trust B p value 
Urgent 4 (44.44%) 4 (14.38%) 
p = 0.07 Non-urgent 5 (55.56%) 22 (84.61%) 
Total 9 26 
 
When one analyses the referrals sent in as non-urgent by general practitioners, 
nearly half (4/9, 44.44%) were re-prioritised as urgent in Trust A compared to 
14.38% (4/28) in Trust B.  Thus, only 5 (55.56%, 5/9) patients who were 
deemed non urgent by both general practitioners and specialists in Trust A 
turned out to have cancer compared to 22(84.61%, 22/26) in Trust B.  This 
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result has been tabulated in Table 5.2.6 above. These differences do not reach 
statistical significance (p = 0.07). 
 
5.2.5 Cancers diagnosed via emergency routes of access 
The emergency routes of access were accident and emergency referrals, GP 
emergency referrals for direct admission to hospital and inter-departmental 
referrals requesting an immediate review of in-patients.  
  
Table 5.2.7:  Distribution of cancers based on emergency routes of access  
 Trust A  Trust B  
Emergency Frequency Percentage Frequency Percentage 
A & E 9 10.47% 21 28.77% 
GP emergency 26 30.23% 31 42.46% 
Inter–departmental 
referrals 
51 59.30% 21 28.77% 
Total 86  73  
 
As seen from Table 5.2.7, there was significant difference in the number of 
referrals via A & E route of access in Trust B as compared to A and similar 
difference was also observed in cancers diagnosed via the inter-departmental 
referral route. Analysis of these results using Chi-square test shows that it 
achieves statistical significance (p <0.001) 
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5.2.6 Overall waiting times 
The overall waiting times for the first clinic appointment with the specialist in 
the hospital were 9.37 days (SD = 15.93) in Trust A and 18.32 days (SD = 30.93) 
in Trust B. This difference was statistically significant (p <0.001) 
 
5.2.7 Waiting times for patients accessed through the elective route 
The following sections present the results of the analysis of the waiting times 
for those patients who had been referred via the elective route of access. 
Patients referred in through the emergency route of access had zero days 
waiting time.  
 
The mean waiting time for all 101 patients referred via elective routes of access 
in Trust A was 16.68 days (SD = 18.08). This was significantly lower (p = 0.02) 
than Trust B (27.54 days, SD = 34.63) 
 
Table 5.2.8 shows the mean waiting times for first clinic appointment for 
patient assessed via elective routes i.e. GP referrals and inter-departmental 
category. The mean waiting times for both GP referrals and inter-departmental 
referrals was significantly less (p = < 0.05) in Trust A as compared to Trust B.  
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Table 5.2.8: Mean waiting times based on GP or inter-departmental 
referrals within the elective routes of access 
 Trust A Trust B  
 
Mean clinic waiting 
time (SD) 
Mean clinic waiting 
time (SD) 
p value 
GP Referrals 18.18 days (19.04) 27.76 days (32.37) 0.01 
Inter-departmental 
referrals 
8.88 days ( 8.67) 26.70 days (42.63) 0.03 
 
5.2.8 Waiting times for patients accessed through the elective route as re-
prioritised by consultants 
The mean waiting time for the first clinic appointment depends on re-
prioritisation by the specialist consultants. Every patient referred to the 
hospital deemed urgent by the GP, is seen as urgent in the clinic unless re-
prioritised by the consultants. 
 
As seen from the Table 5.2.9, there was no significant difference in the mean 
waiting times for the first clinic appointment for cancer patients referred via 
the elective routes of access and re-prioritised urgent by the specialist 
consultants. Similarly, there was no significant difference amongst non-urgent 
referrals as re-prioritised by specialist consultants (Table 5.2.10).  Trust A 
appears to see patients referred via inter-departmental category earlier than 
Trust B, however, no significant difference is achieved which may be due to 
small number of these referrals in the present study. 
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Table 5.2.9: Mean waiting times for referrals via elective routes of access re-
prioritised as urgent by hospital Consultants 
 Trust A Trust B  
Re-prioritised urgent 
by consultants 
Mean clinic waiting 
time (SD) 
Mean clinic waiting 
time (SD) 
p value 
GP Referrals 15.26 days (11.27) 14.12 days (12.26) 0.54 
Inter-departmental 
referrals 
7.53 days (7.06) 22.19 days ( 39.61) 0.07 
 
 
Table 5.2.10: Mean waiting times for referrals via elective routes of access re-
prioritised as non-urgent by hospital Consultants 
 Trust A Trust B  
Re-prioritised non-
urgent by consultants 
Mean clinic waiting 
time (SD) 
Mean clinic waiting 
time (SD) 
p value 
GP Referrals 55.67 days (46.91) 57.77 days (41.68) 0.92 
Inter-departmental 
referrals 
29 days (29.0) 56 days (56.34) 0.69 
 
 
5.2.9 Waiting times for patients accessed through the various elective routes 
as re-prioritised urgent by consultants 
Analysing the urgent category within the various categories of elective route of 
access showed that patients referred to the RACRC in Trust A are seen within 
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14 days and patients referred to the OAFS in Trust B are seen within 34.5 days.  
This difference is statistically significant (p < 0.001).   
 
Table 5.2.11: Mean waiting times for referrals via various elective routes of 
access re-prioritised as urgent by hospital Consultants 
 Trust A Trust B  
Re-prioritised urgent 
by consultants 
Mean clinic waiting 
(SD) 
Mean clinic waiting 
(SD) 
p value 
GP Referrals    
1. RACRC  14.0 days (9.93) - 
< 0.001 
2. OAFS - 34.5 days (13.69) 
3. General outpatient 
clinic 
21.56 days (18.17) 13 days (11.24) 0.05 
Inter-departmental 
referrals 
7.53 days (7.06) 22.19 days (39.61) 0.07 
 
 
As can be seen from Table 5.2.11, patients referred through the elective inter-
departmental route are also seen earlier in Trust A, though this difference does 
not reach statistical significance (p = 0.07).  Cancers diagnosed via the general 
outpatient clinic were seen earlier in Trust B as compared to Trust A. This is 
due the fact that general outpatient clinic is the main clinic in Trust B to assess 
urgent referrals. 
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Results – Section 3 
Tumour stage 
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5.3.1 Introduction 
This chapter presents the anatomical location of the cancers diagnosed in the 
study population in relation to their stage at diagnosis and route of access to 
the specialist services. This section also briefly discusses the relationship 
between deprivation levels (Townsend index) and the stage of cancer at 
diagnosis. 
 
5.3.2 Anatomical location of cancers 
Table 5.3.1 shows the anatomical location of the cancers diagnosed in this 
study. This distribution of cancers across the large bowel was not significantly 
different in the two Trusts (p = 0.29). 
 
Table 5.3.1: Anatomical location of cancers in the two Trusts 
Anatomical location Trust A Trust B 
Caecum 27 (14.4%) 38 (17.5%) 
Ascending colon 13 (7.0%) 19 (8.8%) 
Transverse colon 21 (11.2%) 23 (10.6%) 
Descending colon 11 (5.9%) 6 (2.8%) 
Sigmoid colon 43 (23.0%) 61 (28.1%) 
Rectal 68 (36.4%) 67 (30.9%) 
Multiple 4 (2.1%) 3 (1.4%) 
Total 187 (100%) 217 (100%) 
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5.3.3 Distribution of cancers according to modified Dukes’ stage 
As seen from Table 5.3.2, there was no significant difference in the number of 
modified Dukes’ A cancers diagnosed in the two Trusts (p = 0.81).  
 
Table 5.3.2: Distribution of Modified Dukes’ A and Non-A cancers 
Modified Dukes’ stage Trust A Trust B p value 
A 26 (13.90%) 32 (14.74%) 
0.81 Non A 161 (86.10%) 185 (85.26%) 
Total 187 (100%) 217 (100%) 
 
The above results appear to reject the hypothesis of this research. However, the 
subsequent part of this section drills down into the data to identify the stage of 
cancer at various steps of the access mechanism as shown in flow diagram 1.  
 
5.3.4 Distribution of modified Dukes’ Stage as per anatomical location of 
tumour 
Table 5.3.3 shows the distribution of modified Dukes’ stage as per the 
anatomical location of the tumour.  There were no statistical differences in the 
distribution of Dukes’ A and non-A cancers at any of the anatomical locations 
in the two Trusts.  
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Table 5.3.3: Distribution of stage of cancer as per anatomical location  
Anatomical location Trust A  Trust B  p value 
 Dukes’ A 
Dukes’ 
non-A 
Dukes’ A 
Dukes’ 
non-A 
 
Caecum 3 24 2 36 0.38 
Ascending colon 0 13 0 19 NA 
Transverse colon 1 20 1 22 0.94 
Descending colon 0 11 1 5 0.16 
Sigmoid colon 7 36 13 48 0.52 
Rectal 15 53 15 52 0.96 
Multiple 0 4 0 3 NA 
 187  217   
 
 
5.3.5 Distribution of gender and modified Dukes’ A cancers 
As seen in Table 5.3.4, amongst 26 modified Dukes’ A cancers diagnosed in 
Trust A, there were 57.69% males (15/26) and 42.31% females (11/26). In Trust 
B, there were 62.50% male (20/32) and 37.50% female (12/32). This difference 
showed no statistical significance (p = 0.71). 
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Table 5.3.4: Distribution of modified Dukes’ A cancers and gender 
 Trust A Trust B p Value 
Male  15 (57.69%) 20 (62.5%) 
0.71 Female 11 (42.31%) 12 (37.5%) 
Total 26 (100%) 32 
 
5.3.6 Mean age of the modified Dukes’ A cancers diagnosed 
The overall mean age of patients with modified Dukes’ A cancers diagnosed in 
Trust A was not significantly different (p = 0.54) from Trust B (68.29 days, SD = 
8.01 in Trust A v. 69.78 days, SD = 10.61 in Trust B). 
 
5.3.7 Mean age of the modified Dukes’ A cancers diagnosed in relation to 
gender in the two Trusts  
 
Table 5.3.5: Mean age of the Dukes’ A cancers in relation to gender 
 Trust A Trust B p value 
 Mean Age (SD) Mean Age (SD)  
Male  68.25 days (6.84) 68.05 days (10.47) 0.94 
Female 68.35 days (9.72) 72.67 days (10.67) 0.32 
 
As seen from the Table 5.3.5, there was no statistical difference in the mean 
ages of males and females diagnosed with modified Dukes’ A cancers in the 
two Trusts.  
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5.3.8 Stages of cancers diagnosed in relation to the various routes of access   
This section presents data on the cancer stage at diagnosis in relation to the 
route by which these patients accessed the specialist services.  The results are 
presented for the elective and emergency routes with detailed breakdown of 
the different categories within each route of access. 
 
5.3.8.1 Stages of cancers diagnosed via the elective routes of access   
As seen from Table 5.3.6, there was no statistical difference (p = 0.56) in the 
number of modified Dukes’ A cancers diagnosed via the elective routes of 
access in the two Trusts. 
 
Table 5.3.6: Stage of cancers diagnosed via elective routes of access 
 Trust A Trust B p value 
Dukes’ A 22 (21.78%) 27 (18.75%)  
0.56 
 
Dukes’ non-A 79 (78.22%) 117 (81.25%) 
Total  101 (100%) 144 (100%) 
 
5.3.8.2 Stages of cancers diagnosed via the emergency routes of access   
As seen from Table 5.3.7, there was no statistical difference (p = 0.55) in the 
number of modified Dukes’ A cancers diagnosed via the emergency routes of 
access in the two Trusts. 
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Table 5.3.7: Stage of cancers diagnosed via emergency routes of access 
 Trust A Trust B p value 
Dukes’ A 4 (4.66%) 5 (6.85%) 
0.55 Dukes’ non-A 82 (95.34%) 68 (93.15%) 
Total 86 (100%) 73 (100%) 
 
5.3.9 Stage of cancers diagnosed via different categories of the elective 
routes of access 
As presented earlier, the elective routes of access have been classified into two 
categories i.e. GP referrals and inter-departmental referrals for the purpose of 
analysis. Tables 5.3.8 and 5.3.9 illustrate the stage of modified Dukes’ cancers 
diagnosed via these routes of access respectively. There was no significant 
difference between the two Trusts, in the modified Dukes’ A cancers diagnosed 
via the GP route of access (p = 0.94) and the inter-departmental elective route 
of access (p = 0.21). 
 
Table 5.3.8: Stage of cancers diagnosed via GP category of the elective route 
of access 
 Trust A Trust B p value 
Dukes’ A 19 (22.35%) 25 (21.92%) 
0.94 Dukes’ non-A 66 (77.65%) 89 (78.08%) 
Total 85 (100%) 114 (100%) 
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Table 5.3.9: Stage of cancers diagnosed via inter-departmental category of 
the elective routes of access 
 Trust A Trust B p value 
Dukes’ A 3 (18.75%) 2 (6.67%) 
0.21 Dukes’ non-A 13 (81.25%) 28 (93.33%) 
Total 16 (100%) 30 (100%) 
 
 
5.3.9.1 Sub-analysis of the stage of cancer in relation to the different referral 
mechanisms within the GP category of the elective route of access 
The RACRC in Trust A picked up a total of 69 patients with colorectal cancer 
(see Table 5.2.2).  Of these, 13 patients (18.84%) were at the modified Dukes’ A 
stage.  Comparison between the two Trusts is not possible as the RACRC is not 
available in Trust B.  
 
Similarly in Trust B, the OAFS service picked up a total of 13 cases of colorectal 
cancer (see Table 5.2.2), of which 4 (30.76%) were at Dukes’ stage A.  This 
service is unique to Trust B and hence comparison between Trusts is not 
possible. 
 
However, both Trusts picked up colorectal cancers from the general outpatient 
clinics, 16 in Trust A and 101 in Trust B.  Of these 6 (37.50%) were at Dukes’ 
stage A in Trust A compared with 21 (19.80%) in Trust B.   This is shown below 
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in tabular form (Table 5.3.10). These differences did not reach statistical 
significance (p = 0.14). 
 
Table 5.3.10: Stage of cancers diagnosed via general outpatient clinic of GP 
elective route of access 
 Trust A Trust B p value 
Dukes’ A 6 (37.50% 21 (19.80%) 
0.14 
 
Dukes’ non-A 10 (62.50%) 80 (79.20%) 
Total 16 (100%) 101 (100%) 
 
5.3.9.2 Sub-analysis of the urgency of the referral in relation to the stage of 
the cancers diagnosed  
As detailed in the previous section, the elective route can be accessed urgently 
or non-urgently depending on the type of referral.  Thus, cancers diagnosed via 
the elective routes of access could have been seen as either urgent or non-
urgent. Analysis of the cancers diagnosed through urgent referrals, showed 21 
Dukes’ A cancers out of 93 (22.58%) in Trust A compared to 11 out of 105 
(10.47%) in Trust B (Table 5.3.11).  This difference achieved statistical 
significance (p = 0.02). 
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Table 5.3.11: Stage of cancers diagnosed via urgent elective routes of access 
 Trust A Trust B p value 
Dukes’ A 21 (22.58%) 11 (10.47%) 
0.02 Dukes’ non-A 72 (77.41%) 94 (89.23%) 
Total 93 (100%) 105 (100%) 
 
5.3.9.3 Sub-analysis of the urgent referrals within the elective route of access 
As detailed earlier in section 2 of chapter 5, urgent referrals could either be 
from the GP or the inter-departmental category within the elective route of 
access. On Sub-analysis (Tables 5.3.12 and 5.3.13), there was no difference in 
modified Dukes’ A cancers diagnosed in either category (p = 0.08 for GP 
Category and p = 0.93 for inter-department category). 
 
Table 5.3.12: Stage of cancers diagnosed via GP category of urgent elective 
routes of access 
 Trust A Trust B p value 
Dukes’ A 18 (23.07%) 10 (12.65%) 
0.08 Dukes’ non-A 60 (76.93%) 69 (87.35%) 
Total 78 (100%) 79 (100%) 
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Table 5.3.13: Stage of cancers diagnosed via Inter-departmental category of 
urgent elective routes of access 
 Trust A Trust B p value 
Dukes’ A 3 (20.0%) 1 (3.8%) 
0.93 Dukes’ non-A 12 (80.0%) 25 (96.2%) 
Total 15 (100%) 26 (100%) 
 
5.3.9.4 Sub-analysis of the urgent referrals from the GP category 
To establish precisely what was causing the significant difference noted in the 
urgent elective route of access (Table 5.3.11), the urgent referrals from the GP 
category have been further sub-analysed.  Urgent referrals from general 
practitioners into the elective route of access could be seen either in RACRC, 
general out-patient clinics or OAFS.  Further sub-analysis showed that the pick 
up rate of modified Dukes’ A via RACRC was 19%. None of the four cancers 
diagnosed via OAFS from urgent referrals were early cancers (Dukes’ A).  The 
percentage of modified Dukes’ A cancers diagnosed via general out-patients 
clinic in Trust A were significantly higher than that of Trust B (p = 0.004), as 
shown in table 5.3.14.   
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Table 5.3.14: Stage of cancers diagnosed when GPs accessed the elective 
route via urgent referrals 
 Trust A Trust B 
 RACRC 
General 
outpatient clinics 
General 
outpatient clinics 
OAFS 
Dukes’ A 13 (19.12%) 5 (50.0%) 10 (13.33%) 0 (0%) 
Dukes’ non-A 55 (80.88) 5 (50.0%) 65 (86.67%) 4 (100%) 
Total 68 10 (100%) 75 (100%) 4 (100%) 
 
The above data (Table 5.3.14) shows that there was a significantly higher pick 
up rate of early colorectal cancer (Dukes’ stage A) in Trust A compared with 
Trust B, when general practitioners sent patients into the specialist service 
using an urgent referral through the elective route.  The possible reasons for 
this will be discussed in the next chapter. 
 
5.3.9.5 Sub-analysis of the non-urgent referrals within the elective route of 
access   
There was no sub-analysis done on the cancers diagnosed from non-urgent 
referrals due to the small number in Trust A (8 out of 101). 
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5.3.10 Relationship between the deprivation levels (Townsend Index) and 
stage of cancer at diagnosis 
 
The mean Townsend index for study population was +0.64 (SD + 2.44) with a 
range of – 6.00 to + 7.00.  Table 5.3.15 shows the distribution of patients and the 
population of the catchment areas of the study according to Townsend Index (TI) 
categories. As seen from this Table, more than 85% of population in the valleys 
belong to median to deprived category and there is no clear correlation 
between deprivation levels and incidence of colorectal cancer.  
 
Table 5.3.15: Distribution of patients and the population of the catchment areas of 
the study according to Townsend Index (TI) categories 
 
Category of TI Population distribution  Cancer distribution 
Most Affluent 7.94% 18 (4.5%) 
Next Affluent 4.76% 59 (14.6%) 
Median 20.63% 159 (39.1%) 
Next Deprived 39.68% 87 (21.5%) 
Most deprived 26.98% 81 (20.0%) 
 
The mean Townsend index was higher for patients who were sent in as urgent 
referrals (TI = +1.13, SD 2.1), compared to patients who presented as non-
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urgent referrals (TI = +0.34, SD 2.6).  This difference achieves statistical 
significance (p < 0.005) 
 
Table 5.3.16 illustrates that the index was higher for patients with modified 
Dukes’ D cancers as compared to the earlier stages. However, this was 
statistically insignificant.  
 
 Table 5.3.16: Townsend Index and modified Dukes’ Stage 
Modified Dukes’ stage Mean TI SD 
A +0.78 2.65 
B +0.54 2.42 
C +0.43 2.43 
D +1.13 2.2 
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Results – Section 4 
Summary of significant findings 
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Summary of significant findings 
 
1. More of the cancers diagnosed in Trust B  were seen as elective 
2. Of the cancers diagnosed from general practitioners referrals, more patients 
were sent in  as ‘urgent’ to Trust A 
3. Of the cancers diagnosed from urgent GP referrals, more patients were seen 
as ‘urgent’ in Trust A (less re-prioritisation by consultants). 
4.  Of the cancers diagnosed from urgent GP referrals, more patients were re-
prioritised as ‘non-urgent’ in Trust B 
5. Higher percentage of cancers diagnosed via A & E in Trust B and inter-
departmental emergency referrals in Trust A 
6. Overall waiting times for the first clinic appointment (applicable only to 
‘elective’) was less in Trust A 
7. Waiting times for both categories of elective route of access (the GP and the 
inter-departmental ) were less in A 
8. No difference in waiting times once the patient was deemed urgent by 
either Trust 
9. Higher pick up rate of early colorectal cancer (Dukes’ stage A) in Trust A 
compared with Trust B, when general practitioners sent patients into the 
specialist service using an urgent referral through the elective route. 
10.  The majority of population of the catchment areas of this study belong to 
the more deprived areas.  
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11. Patients from deprived areas are more likely to present as an urgent 
referral. 
12. Townsend index was higher for modified Dukes’ D cancers, but this was 
not statistically significant. 
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Discussion 
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6.1 Introduction 
Colorectal cancer is one of the most common malignant diseases in the western 
world. It affects men and women equally and the incidence increases with age 
(2). Colorectal cancer is the third commonest cause of cancer related death 
(after breast and lung cancer) in the UK (1).  There are over 34,000 new cases of 
colorectal cancer diagnosed in the UK every year and approximately 17,000 
deaths (1). 
 
Survival in colorectal cancer is directly related to the stage at diagnosis (34, 35). 
There is strong evidence that asymptomatic patients present with less 
advanced disease and thus have better survival (36, 93, 103). This is the basis 
for the colorectal cancer screening programme that has recently been 
introduced in England and is due to start in Wales shortly. 
 
Approximately 25% of patients in the UK present with locally advanced or 
metastatic disease (6-8).  Patients with colorectal cancer occasionally tend to 
develop non-specific symptoms leading to emergency presentation with 
advanced disease (3). Therefore, it is important to have effective mechanisms in 
place to assess and diagnose these cancers early. 
 
 Routes of access play a crucial role in early diagnosis. It is well known that a 
referral made to a non–surgical speciality can significantly delay diagnosis (47, 
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104).  There are different models of health care delivery to allow access from 
the primary care sector into the specialist colorectal services in the secondary 
care sector.  There are several components that are constituents of a given 
model of health care delivery. Differences exist in each of these components 
such as the presence or absence of strict referral criteria, designated referral 
pathways, prioritisation protocols in the specialist units and in the resources 
available to assess patients with high risk symptoms.  There are several 
publications which have looked at the impact of many of these individual 
components (3, 20, 23, 25, 48, 49, 64, 68, 70, 71, 98, 105).   However, there have 
been no studies looking at the impact of whole models in their entirety. 
 
The aim of the present study was to compare the clinical effectiveness of two 
service models in terms of diagnosis of early colorectal cancers (modified 
Dukes’ A). 
 
6.2 Sample representativeness 
In the present study, the percentage of the patients excluded from each of the 
two participating Trusts was not significantly different. The reasons for 
exclusion were also similar. There were two main reasons for exclusion from 
this study.  One was lack of staging information because of unsuitability for 
surgery due to severe co-morbidities.  Another reason was that in some unfit 
patients where, although pre-operative staging was carried out, it did not show 
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any metastatic disease. These patients were obviously not Dukes’ D cancers but 
whether they were Dukes’ A could not be ascertained.  These patients were 
excluded because, without a resection specimen in these cases, staging 
information was not available.  According to the 2001 census (26), the two 
valleys that form the catchment area of the two Trusts in this study (Merthyr 
and Rhondda Cynon Taff) were amongst the top 5 areas in the UK with high 
proportion of the general population suffering from long term illnesses.  
 
This study tries to identify similarities of the study sample with all Wales data 
in terms of mean age and gender. This does not attempt to prove that study 
sample is representative of Welsh population.  This is because the all Wales 
data includes all patients diagnosed with colorectal cancer whereas the study 
sample has been derived after the application of rigorous exclusion criteria, as 
described in Methodology. 
 
6.3 Sample demographics 
The incidence of rectal cancer peaks in the 60 – 69 years age group and 
increases with advancing age (2, 106). The figures are similar for colon cancer. 
The reported incidence of the disease in patients below 40 years varies from 2% 
- 4% (107-109). The mean age of presentation was similar in the two Trusts 
which was also in keeping with the available data from the UK literature (22). 
A previous study performed in Trust A has also shown similar age distribution  
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(23). The gender distribution in the previous study published from Trust A also 
showed similar trends (23).    
 
6.4 Routes of access 
There were significant differences in the presentation of cancers to both  
secondary care Trusts. Trust A had a larger number of patients presenting via 
the emergency route of access when compared to the Trust B. A trend similar 
to the pattern in Trust A has been shown in the another study published in 
British Journal of Surgery in 1992 (92).  This could be due to patient education, 
patients’ perception of their symptoms, available medical facilities e.g. access to 
GP or out of the hours service, socio-economic status or profession (13, 110). A 
study by Cockburn et al concentrated on healthy adults with symptoms of 
rectal bleeding (85). The study showed that of those patients who experienced 
rectal bleeding, one third never sought medical advice. A similar study looking 
at the management of colorectal cancer highlighted that social influences such 
as profession, type of education, marital status and availability of health 
insurance had a significant influence on treatment delay, as did the level of 
clinical experience of the physician first contacted (84).  Delays in patients 
accessing health care can also be associated with past anxiety or depression as 
highlighted in a study by Robertson et al (111).   
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The catchment area for Trust A is more deprived than that of Trust B in terms 
of unemployment, long term illness and also educational qualifications (26). 
These factors do contribute in the decision making of patients such that they 
tend to approach the hospital directly (thus accessing the emergency route) 
instead of their own general practitioners.  Another explanation for the 
differences in the utilisation of the emergency route of access between the two 
Trusts, might be a wide variation in the way general practitioners manage 
rectal bleeding or inconsistent knowledge among general practitioners about 
the existing guidelines (112).  
 
6.5 Elective routes of access 
As discussed in the Results chapter (section 2), the elective route of access is 
used either by general practitioners to refer patients to the specialist services or 
by other hospital consultants. There was no difference in the percentage of the 
cancers diagnosed via either GP or inter-departmental category between the 
two Trusts.  
 
The Department of Health introduced national urgent referral guidelines in 
2000, based on higher risk symptoms and signs for colorectal cancer – “the Two 
Week rule”. All units are now required to see at least 95% of patients who meet 
these criteria for urgent referral within two weeks (14 calendar days).  These 
referral guidelines were revised by the colorectal unit in Trust A and were 
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adopted by Trust B as well , as discussed in chapter 2 (23). These guidelines 
were incorporated into simple forms which helped general practitioners to 
prioritise patients for early referral to the rapid access clinics (Appendix I). In 
Trust A, they were made available to general practitioners through meetings 
conducted by the consultant surgeon at regular intervals to educate as well as 
to highlight the importance of the guidelines. Trust A has also published its 
unique education programme,  arranged by the colorectal unit in conjunction 
with the Local health Board for general practitioners to gain insight into 
referral pathways and secondary care mechanisms(113).  Trust B has not had a 
similar programme for the dissemination of the referral form and this is the 
most likely explanation for the difference in the utilisation of these designated 
forms seen in Section 5.2.4.  
 
In Trust B, an audit of the appropriateness of general practitioner letters was 
conducted in 1997 (27). It was found that the overall standard of these letters 
was poor with inadequate information (unpublished data, presented at local 
and regional meetings). Hence, all the general practitioners of the catchment 
areas of Trust B were visited and educated regarding colorectal cancer and 
rectal bleeding. This was performed prior to the introduction of the designated 
form. There are large proportion of patients are referred with use of letters by 
general practitioner to Trust B. The standard of these letters at present is 
beyond the scope of this study, but as highlighted earlier, there may be need to 
 107 
re-visit the general practitioners of the Trust B to emphasize the use of the 
designated referral form. 
 
There are significantly more patients sent in as urgent by general practitioners 
in Trust A (Table 5.2.4).  This could be the result of general practitioners’ 
awareness of the referral guidelines or presence of the designated referral form. 
These referrals once received in the two Trusts are re-prioritised by the 
specialist consultants as either urgent or non-urgent. In Trust A, the majority of 
referrals to RACRC were on designated referral forms and hence did not 
require re-prioritisation by specialist consultants and were seen as urgent 
(Table 5.2.5). 
 
The standard mode of referral is a letter from general practitioners (81) and this 
is the preferred method for general practitioners to access the specialist service 
in Trust B. All these GP referrals including those marked urgent were re-
prioritised and a significant number of referrals were downgraded as non-
urgent (Table 5.2.5). This suggests that the presence of a designated referral 
form is important for general practitioners to refer patients urgently to the 
specialist consultants. 
 
A surgical unit at Crewe has developed a scoring system based on the presence 
of symptoms and symptom complexes to produce a computer generated 
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numerical score to identify patients with a higher likelihood of colorectal 
cancer (82) though this is not yet been accepted widely. In order to avoid the 
controversies around prioritisation, a study by Scott et al suggested that all 
patients referred to specialist clinics should be seen on an urgent basis until a 
more accurate method of identifying the highest risk patients is implemented 
(114). This could lead significant impact on non-urgent referrals (79).  
 
As seen in Table 5.2.6, analysis of patients referred as non-urgent by general 
practitioners showed that a higher proportion were re-prioritised as urgent in 
Trust A, though this difference does not achieve statistical significance.  
Though these data suggest that Trust A is better at identifying urgent cases, 
there may be a significant increase in the workload and may actually reflect an 
inefficient service.  In fact, a previous study from Trust A has highlighted that 
increase in the number of urgent colorectal referrals affects the waiting time of 
non-urgent colorectal and non-colorectal referrals (52). The possible effect of 
such consultant re-prioritisation on the management of these patients is outside 
the scope of this study.  
 
6.6 Emergency routes of access 
There is a variation of 25%  to 42% in the proportion of colorectal cancers 
diagnosed via emergency routes of access in the published literature (44, 46, 67, 
83, 92).  This study has shown that the figures for Trust A and Trust B were 
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46% and 34% respectively. The higher proportion of access through the 
emergency route in Trust A may be due to socio-economic factors as discussed 
in 6.1 and 6.3 above.  
 
 A study from South Thames District Health Authorities has shown that 
emergency presentation is higher for rectal cancer as compared to colon cancer 
(115), though this has not been demonstrated in the present study. As 
discussed earlier in section 5.2.7, there are three main categories of emergency 
routes of access.  There were a significantly lower percentage of cancers 
diagnosed via A & E in Trust A as compared to Trust B.  This could be a 
reflection of the availability of the designated referral form and the RACRC for 
the elective route of access.  
 
Conversely, a higher percentage of cases were diagnosed via the inter-
departmental referral route in Trust A. This difference was not seen in the 
inter-departmental category of the elective route.  This suggests that the same 
socio-economic factors highlighted above, may have the effect of increasing the 
overall emergency workload in Trust A, across all departments. Interestingly, 
many of the cancers referred from these sources are right-sided colonic cancers 
(16 right colonic cancers in Trust A versus 4 in Trust B).  The probable 
explanation for this is that right sided cancers often present with anaemia, 
which may manifest with symptoms of lethargy, fainting, shortness of breath 
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etc. necessitating admission under the care of physicians rather than colorectal 
surgeons (116, 117). 
 
Colorectal cancer patients admitted as emergencies tend to have more 
advanced disease and hence higher mortality and morbidity and therefore 
require far greater resource provision (44). Earlier referral appears to be useful 
in preventing this emergency presentation (44, 118) and related complications 
(119).  It may not, in itself, significantly influence survival. However, this is 
beyond the scope of present study. 
 
6.7 Waiting time for first clinic appointment 
The overall waiting times in the present study was significantly less in Trust A 
due the fact that Trust A diagnoses larger number of cancers via the emergency 
route of access.  The waiting time for the emergency route is zero as patients 
are seen and assessed the same day. 
 
The mean waiting time for the first outpatient clinic for cancers diagnosed via 
the elective route was significantly less in Trust A . On further sub-analysis of 
the categories within the elective route of access, the mean waiting times for 
the GP referral and Inter-departmental category were both significantly less in 
Trust A.  This difference is explained by the fact that the elective route of access 
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includes urgent and non urgent referrals.  As seen in section 5.2.4, Trust A has 
a significantly higher percentage of urgent referrals. 
 
Further analysis showed that the urgent category within the elective route of 
access showed no differences between the two Trusts.  This is explained by the 
fact that in order to meet government regulations, once patients have been  
categorised as urgent they need to be seen within two weeks(1, 6, 14).  As can 
be seen from Section 5.2.9, patients referred to the RACRC in Trust A are seen 
within 14 days and patients referred to the OAFS in Trust B are seen within 35 
days.  This difference is statistically significant (p < 0.001).  However, RACRC 
and OAFS are two distinct type of clinics. RACRC is run by consultants to 
assess and rule out or diagnose colorectal cancer in patients with high risk 
symptoms. OAFS on the other hand is only an evaluation service to identify the 
cause of the rectal bleeding and not used primarily as a service to diagnose 
cancers (personal communications). Patients referred through the elective 
inter-departmental route are also seen earlier in Trust A, though this difference 
does not reach statistical significance (p = 0.07). Cancers diagnosed via the 
general outpatient clinic were seen earlier in Trust B. This is due the fact that 
general outpatient clinic is the main clinic in Trust B to assess urgent referrals. 
 
Thus, the significant difference seen in the waiting times for the overall elective 
route of access is explained by the fact that the RACRC is more expeditious 
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than the OAFS and the specialists in Trust A see inter-departmental referrals 
earlier than in Trust B. A referral made to a non–surgical specialty can 
significantly delay diagnosis of colorectal cancer. This has been well recognised 
with colorectal and other cancers (1, 47). 
 
An audit published from Trust A, highlighted that colorectal sub-specialisation 
has resulted in a significant delay in the management of patients with non-
colorectal diseases and showed that routine colorectal referrals had to wait for 
nearly 84 days for their first appointment (52). The results from the present 
study have further highlighted these concerns in both Trusts. This is due to the 
fact that non-colorectal and routine colorectal referrals are normally seen and 
dealt in general outpatient clinics along with general surgical referrals. A 
similar difference in waiting times for urgent and non-urgent referrals was 
seen across the whole of the UK for various cancers (120). A study by Oslon et 
al has highlighted further delay amongst patients undergoing elective surgery 
for non-cancer related causes. However, this is beyond the scope of this study 
(121). 
 
The two-week standard had been used as a safety net by general practitioners 
to refer patients to specialist clinics. This has led to large number of 
inappropriate referrals flooding the clinics (48). At least half of those referred 
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as urgent cases do not fit the national guidelines (3). This has also been true in 
the present setting (52).  
 
6.8 Modified Dukes’ stage 
Patients with early disease (modified Dukes’ A) have been shown to have 5-
year survival of 95%. Survival decreases with later cancer stages (2, 122). 
Hence, it is important to diagnose colorectal cancers early.  
 
The overall pick up rate of Dukes’ A colorectal cancers in the study sample was 
more than the overall UK pick rate (13.9% in Trust A and 14.7% in Trust B 
compared to 10% for the UK (30).  This is in spite of the exclusion of 
malignancies identified in polyps. Thus both the Trusts in this study have very 
good pick-up rates for early cancers.  In the Trent/ Wales audit, modified 
Dukes’ A cancer accounted for only 10% of all the colorectal cancer diagnosed. 
Pick up rate of Dukes’ A cancer in the published literature varies between 4% 
to 18% across the world (5, 20, 95, 96).  In the present study, the percentage of 
Dukes’ A cancers diagnosed in the two Trusts was not statistically different.  
This result appears to reject the hypothesis of the present thesis. However, 
models of health care delivery have various components as shown in Flow 
diagram 1 and the specific pick up rate of Dukes’ A cancers will be different for 
individual components. 
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A study published by Shankar et al performed in Trust A highlighted increases 
in the modified Dukes’ A cancer after initiation of sub-specialisation (23). It 
went from 11% in 1993 to 23% in 2000. In the present study, it is 13.90% in 
Trust A. This is due to exclusion criteria, as the present study excluded cancers 
diagnosed in the endoscopically resected polyps, whereas the study by 
Shankar et al (2000) included endoscopically resected polyps as Dukes’ A 
cancers (23). It could be also due to better staging facilities now being available.  
In 2000, X-ray chest and ultrasound of the liver were standard staging modality 
for metastatic assessment whereas in the present study it was computed 
tomography of the chest, abdomen and pelvis.  There is evidence to show that 
with better staging modalities and protocols, more distant metastases will be 
identified (123, 124), thus reducing the overall proportion of early cancers 
detected.   
 
The overall pick up rate pf modified Dukes’ A colorectal cancer diagnosed in 
the Wales as per the Trent /Wales audit was 10% which is less when compared 
with the two Trusts (5). This is could be due to the fact that the there has been 
an exclusion of cases where the staging was not carried out in the present 
study. This could influence the percentage of the Dukes’ A cancers diagnosed. 
The other reason could be use of the modified ACPGBI criteria used by the two 
Trusts as discussed in the Chapter 2 Background (2.10). The reduction in the 
age group of patients from 60 years to 50 years could be the reason for the high 
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percentage of early colorectal cancers diagnosed as flexible sigmoidoscopy is 
performed ten years earlier in symptomatic patients in the study group. 
 
6.9 Modified Dukes’ stage and routes of access 
Asymptomatic patients present with less advanced disease, thus have better 
survival. Early cancer diagnosis in these patients is best achieved by screening 
the population (37). A study by Waldron et al suggested that 66% of patients 
who present as emergency have potentially curable disease (46). Introduction 
of a fast-track service to meet the two-week target has resulted in a trend 
towards fewer emergency presentations with colorectal cancer (63). Colorectal 
cancers diagnosed via direct surgical referral tend to be at an earlier stage 
compared to those referred via accident and emergency (98). These findings are 
supported by the present study in that there were larger numbers of Dukes’ A 
cancers diagnosed via elective routes as compared to emergency routes. This 
was equally true for both the Trusts.  Chohan et al highlighted that there was a 
higher incidence of metastatic disease in patients referred as fast track referrals 
(64). This was in contrast to the study performed by Lamah et al which showed 
that only one of 70 patients diagnosed via fast track service had metastatic 
disease (49). 
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6.10 Modified Dukes’ stage and various categories of elective routes of 
access 
There was no significant difference in the Dukes’ A stage in the two Trusts in 
patients diagnosed via various elective category of referral i.e. GP and inter-
departmental. However, there were higher percentage of Dukes’ A cancers 
diagnosed via inter-departmental category of elective route in Trust A (18.75%) 
as compared to Trust B (6.67%).  Although, this appears to be a trend, there is 
no statistical significance, possibly due to small numbers.   
 
Elective referrals to the specialist service could be either urgent or non-urgent. 
Analysis of the cancers diagnosed through urgent referrals (Section 5.3.9.2), 
showed that there were significantly higher numbers of Dukes’ A cancers 
diagnosed in Trust A (21/93) compared with Trust B (11/105). Detailed sub-
analysis of the urgency of the referral in relation to the elective routes of access 
shows that 19% of cancers diagnosed via RACRC were Dukes’ A cancers. 
OAFS did not diagnose any Dukes’ A cancer. This may be explained by the fact 
that RACRC utilised the modified ACPGBI criteria (29) for classification of 
urgent referrals whereas OAFS is based on only simple criteria like age > 45 
years and rectal bleeding. The differences could also be explained by the fact 
that RACRC is accessed by a designated referral form. Though a previous 
study from Trust B has shown that the general practitioners have accepted the 
nurse-led OAFS (28), this study seems to suggest that in the present 
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circumstances with specific government guidelines, GP acceptance may need 
to be re-assessed.  Furthermore, OAFS has not been shown to be a particularly 
expeditious service (Section 5.2.9) and that may be an explanation as to why 
general practitioners are not using it for urgent cases. A study published in 
2000 from these two Trusts compared the RACRC  with OAFS (25) and showed 
similar stage migration in terms of Dukes’ A cancer diagnosed via both these 
services.  This has not been supported by the present study.  However, the 
study published in 2000 did not look into whether the referrals were urgent or 
non-urgent.  Studies in the literature have published varied results of cancers 
diagnosed via their fast track clinics.  A study by Walsh et al picked up 15% 
Dukes’ A cancers via fast track clinics (14). A Study by Chohan et al produced 
contradictory finding of higher pick up of cancers with metastatic disease 
(Dukes’ D) as compared to Dukes’ A which was 12% (64).  
 
 Continuing with the sub-analysis of the urgent referrals within the elective 
route of access, a significantly higher proportion of early cancers in this study 
were diagnosed from urgent referrals via general outpatient clinics in Trust A 
as compared to B (Table 5.3.14).  This difference is explained by the fact that the 
vast majority of urgent referrals are seen in RACRC rather than the general 
outpatient clinic in Trust A. All the urgent referrals are seen in the general 
outpatient clinic in Trust B.  However, this study has not looked at the overall 
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workload of any of these services and therefore, cannot comment on the 
efficiency of these individual services. 
 
General outpatient clinics are a standard form of access for patients with a 
wide range of problems. With the use of rapid access clinics for urgent cases 
with suspected cancer referrals, the general clinics are mainly used for non-
urgent and benign referrals leading to low pick up rate of cancers in these 
clinics (20).  This is true for Trust A. However, in Trust B, where the general 
surgical clinic forms the backbone of the access mechanism, increased usage of 
a designated referral form with strict criteria by the referring general 
practitioners could improve the pick up rate of early cancers.   
 
In summary, there appears to be no significant difference in the overall pick-up 
rate of Dukes’ A colorectal cancers between the two models of health care 
delivery.  However, detailed sub-analysis of the urgency of the referral in 
relation to the stage of the cancer diagnosed shows that there was a 
significantly higher pick up rate of early colorectal cancer (Dukes’ stage A) in 
Trust A compared with Trust B, when general practitioners sent patients into 
the specialist service using an urgent referral through the elective route (Table 
5.3.14). The fact that the differences are so subtle is hardly surprising when 
comparing two systems of health care delivery, both of which are performing 
well above the national average in terms of the diagnosis of early colorectal 
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cancer.  This is especially true, when examined in the context of the particularly 
high levels of socio-economic deprivation in the catchment population where 
these health care delivery systems operate.  
 
6.11 Deprivation levels (Townsend Index) and stage of colorectal cancer 
 This study highlights that there is a wide variation of the Townsend index in 
patients diagnosed with colorectal cancer.  The two Trusts in this study serve a 
particularly deprived area of Wales as shown by the fact that more than 85% of 
this population belonged to median and deprived categories. The overall range 
of the Townsend index for the whole of the Wales varies from -8.23 to + 11.88 
and that of the catchment population is -8.23 to +9.59.  
 
People with colorectal cancer tend do develop non-specific symptoms leading 
to emergency presentation with advanced disease (3). This study highlights 
that patients with high Townsend scores are more likely to be referred as an 
urgent referral to the clinic or via Accident and Emergency department or as a  
GP emergency referral. Hence in turn, they are also likely to have significant 
risk of having an urgent/emergency operation and consequently have poorer 
outcomes (1). 
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There is increasing evidence of variation in treatments being provided to 
cancer patients in different socio-economic groups (125). Women with breast 
cancer living in deprived areas have been found to be more likely to receive a 
mastectomy than breast-conserving therapy in comparison with those living in 
affluent places in the UK (125). Similarly, variations in chemotherapeutic 
regimes have been seen in the management of colorectal cancer in the USA. 
However, this is the beyond scope of this study. 
 
A Scottish audit showed that there was no consistent evidence that patients 
from deprived communities present with more advanced disease for colorectal 
cancer (126). In the present setting, patients with modified Dukes’ D stage do 
have a higher Townsend index as compared to the other stages but statistical 
significance has not been achieved (Table 5.3.16). 
 
6.11 Potential cost implications 
Cost is another major issue in the management of patients with colorectal 
cancer. Cost per patient should ideally be calculated from the time of referral to 
the diagnosis, treatment and include the after-care of the patient.  These costs 
vary widely and are affected by various factors, for e.g. blood transfusion (127), 
screen detected or asymptomatic patients etc. Costs have been reported to be 
 121 
significantly less for Dukes’ B and Dukes’A cancers, in both the pre-diagnosis 
phase and 12 months after diagnosis (128).  
 
Life time costs of managing colorectal cancer diagnosed in the early stages is 
lower than when the cancer is a diagnosed at a late stage (129). The cost of the 
hospitalisation has been reported to account for 61% to 65%, as compared to 
2% for diagnosis and staging.  Most of the studies do not take in to account 
non-medical costs, such as the patient’s time associated with travel to, waiting 
for or seeking medical care (70, 130). These can account for a substantial 
amount, almost 20% of medical costs in the initial period of care (diagnosis and 
primary treatment) and nearly 40% in the terminal phase (130, 131). 
 
RACRC with flexible sigmoidoscopy may use more resources as compared to 
general outpatient clinics, in terms of more medical and nursing staff, use of 
consumables, overheads etc. The cost effectiveness of such a service would 
depend not only on the number of cancers diagnosed, but also on the overall 
number of referrals seen. The stage at which cancers are diagnosed also affects 
the cost of post-operative care. Hence, a high number of early cancers 
diagnosed from a fast track service may result in long term overall savings. 
There is evidence in the published literature to suggest that open access 
sigmoidoscopy or colonoscopy services reduces costs when compared to 
consultant-led clinics, with no differences in the colonic diseases diagnosed 
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(70). The cost per cancer patient diagnosed via various routes of access is 
beyond the scope of this study.  
 
6.12 Strengths of this study 
This is a unique study, which has compared two distinct models of health care 
delivery. The literature review has shown that various individual components 
of different models of health care have been studied in isolation. However, no 
previous study has compared whole models in their entirety. This study was 
aimed to assess the pick up rate of Dukes’ A cancers and a very systematic 
approach has been undertaken to identify the differences in the two Trusts 
with a view to correlating the various steps in the process of health care 
delivery with the stage of colorectal cancer at diagnosis.  
 
6.13 Limitations of this study 
The study has good data collection, but it does not take into consideration the 
overall number of patients seen in the various categories of routes of access 
during the period of this study. That information would help to assess the 
efficiency of each of these components with regard to the pick up rate of early 
colorectal cancers as a proportion of the total number of patients seen in the 
clinic.  
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The sample size of this study could have been increased by collecting data over 
a longer period.  A larger sample size may have shown up more significant 
differences and strengthened this study further.  
 
Both the Trusts in this study have a higher pick up rate of early colorectal 
cancer than the national average.  This could be a limitation of this study in 
that it has attempted to compare two exceptionally good models of health care 
delivery and therefore, the differences seen have been subtle.  
 
This study has not taken into consideration detailed impact from the socio-
economic status of the catchment population. Future studies may need to 
consider this issue in depth.  
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Chapter 7 
Conclusions 
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It is safe to conclude from this study that there appears to be no difference 
between the two systems of health care delivery in their overall ability to pick 
up early colorectal cancers.  However, detailed analysis of the constituent 
components of each model has shown specific differences.  
 
This study has shown that the combination of a rapid access clinic with flexible 
sigmoidoscopy in association with the modified ACPGBI criteria incorporated 
in a specially designed referral form does reduce waiting times and results in a 
higher pick up of early colorectal cancers.  There is conclusive evidence that 
there was a significantly higher pick up rate of modified Dukes’ stage A 
colorectal cancer in Trust A compared with Trust B, when general practitioners 
gain access to the specialist service using an urgent referral through the elective 
route.  
 
There is no significant difference in the waiting times for the first clinic 
appointment for the patients deemed urgent in the either of the Trusts.  
 
It is also possible to conclude that both these models of health care delivery are 
exceptionally good as the pick up rate of early colorectal cancers is higher than 
the national average in both the Trusts.  This difference in the pick up rate of 
early cancers could be due to the modified ACPGBI criteria adopted in these 
two models of health care delivery. 
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This study demonstrates that patients with colorectal cancer from deprived 
areas are more likely to be referred as urgent referrals as well as require urgent 
intervention.  They may have poorer outcomes in terms of stage of disease at 
diagnosis as well as postoperative mortality, though, due to sample size, 
statistical significance has not been achieved. 
 
Finally, this study suggests that the presence of a dedicated specialist service is 
probably more important than any specific model of health care delivery for 
the early diagnosis of colorectal cancer. 
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Chapter 8 
Recommendations 
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8.1 Recommendations  
• General practitioner education should be instituted to highlight referral 
criteria to increase the appropriateness of referrals.  This is particularly true 
for Trust B. 
• Use of the designated referral form by general practitioners should be made 
mandatory. Both Trusts still get a lot of referrals through letters, but this is a 
particular issue in Trust B. 
• Trust A should carry out regular audits of the appropriateness of the urgent 
referrals to the RACRC to optimise the elective workload. 
• Trust A should carry out audits of the referrals through the emergency 
route of access to optimise the emergency workload.  
 
8.2 Recommendations for future research 
• Studies to compare both these models with other systems which are 
performing below the national average in terms of picking up early 
colorectal cancers may help to clarify the effectiveness of some of the 
specific components.  
• Detailed studies should be undertaken regarding the cost implications of 
both these models of health care delivery. 
• Future research could study the impact, if any, of the socio-economic status 
of the study population in relation to specific models of health care delivery 
and their correlation with pick up rates of early colorectal cancer. 
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APPENDIX I 
North Glamorgan NHS Trust 
REFERRAL FORM FOR THE COLORECTAL CLINIC 
PART A (to be completed by the referring GP) 
 
Patient Name: …………………………….     NHS No: ……………….……  Hosp No: ………………… 
 
DOB: ………………….... Patient Address…………………………………………………………………... 
 
………………………………………………………………………….…      Patient Tel No: ………………… 
 
Date of referral….………….…Date referral received………………..Date seen in colorectal clinic……………….. 
 
PLEASE TICK THIS BOX IF YOU FEEL THAT THIS PATIENT IS AT HIGH RISK  
OF BEING DIAGNOSED AS HAVING COLORECTAL CANCER SO THAT THE  
PATIENT CAN BE SEEN WITHIN 10 WORKING DAYS 
Because of one or more of the following high risk criteria for urgent referral: 
 
1. Rectal bleeding WITH a change in bowel habits to looser stools  All Ages       
 and/or increased frequency of defaecation persistent for 6 weeks. 
2. Change in bowel habit as above WITHOUT rectal bleeding and  Over 50 years   
 persistent for 6 weeks. 
3. Rectal bleeding persistently WITHOUT anal symptoms.   Over 50 years   
4. A definite palpable abdominal mass.      All Ages   
5. A definite palpable rectal mass.      All Ages   
6. Iron deficiency anaemia:  
 Below 10grams in post-menopausal women     All Ages   
 Below 11grams all men 
 If this is the reason for referral, please mention Hb…………….on (date)……………… 
7. Abdominal pain with significant weight loss.    Over 50 years   
 
If none of the above criteria apply, but you still want the patient to be seen in the colorectal clinic, please 
indicate below and a routine appointment will be sent to the patient. 
 
Rectal bleeding      Diarrhoea  Constipation  Weight loss        Abdominal pain 
 
Other Comments: ……………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
Relevant medication:  Anticoagulants Other ……………………………………. 
 
Relevant Family History: ………………………………….………………………….. 
 
Relevant Past Medical History: ……………………………………………………….. 
 
Referring GP ……………………………  Address ………………………………………………………….. 
…………………………………………………………………………………………………………………… 
When you have filled in this form return it urgently to the Medical Records Dept. at Prince Charles Hospital for 
your patient to be seen at the colorectal clinic.  If you have ticked the top box and selected one of the high risk 
criteria, the patient will be sent an appointment within 2 weeks.  Otherwise, a routine appointment will be 
sent.  There is no need to send any additional information or letter. 
Prof P N Haray – Consultant Surgeon   Mr A G Masoud – Consultant Surgeon  
Mr. A. Joseph – Associate Specialist 
Medical Records Phone: 01685 728315   Fax: 01685 728480 
  
APPENDIX I 
 
PART B (to be completed at Colorectal Clinic)  
 
Additional History ……………………………………………… 
 
……………………………………………………………………. 
 
……………………………………………………………………. 
 
Examination: 
 General …………………………………………………... 
 
 ……………………………………………………………. 
  
 Abdomen ………………………………………………… 
 
 ……………………………………………………………. 
 
 
 PR – Inspection …………………………………………. 
 
 …………………………………………………………….           Ant 
  
PR – Palpation ………………………………………….. 
 
…………………………………………………………….   Post 
 
 
Proctoscopy ………………………………………………           Ant 
 
……………………………………………………………. 
 
…………………………………………………………….             Post 
 
 
Sigmoidoscopy ………………………………………….. 
 
……………………………………………………………. 
                 A 
……………………………………………………………. 
 
            P 
Any Procedures …………………………………………………………………………………………….. 
 
………………………………………………………………………………………………………………… 
  
Investigations  FBC  U&E  LFTs 
  USS  Ba enema  Colonoscopy 
  Flex. Sigmoidoscopy  Other…………….. 
 
Provisional Diagnosis ……………………………………………………………………………………….. 
 
Plan …………………………………………………………………………………………………………… 
 
………………………………………………………………………………………………………………… 
 
Seen by: ………………………………..…Consultant/Assoc. Specialist/SPR     Date: ………………….. 
Patient Sticker 
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Proforma for Data Collection 
Patient’s demographics 
1 Hospital Number:  _______ 
2 Unique identifier:  _______ 
3 Post code:    _______ 
4 Date of birth:   _______ 
5 Age:    _______  years. 
6 Sex:    Male  Female 
General Practitioners (GP) details 
7 GP:   _______ 
8 GP surgery:  _______ 
Clinic Details 
9 Date of referral by GP:   _____________ 
10 Date of referral received in the hospital: _____________ 
11 Date 1st seen in the clinic:     _____________ 
12 Waiting period from GP referral to 1st clinic appointment _____________ days 
13 Route of access Elective  Emergency 
14 Referral prioritisation by GP   Urgent Non-urgent  
15 Referral prioritisation by specialist  Urgent Non-urgent 
 
Appendix II 
 
16 Modes of referral 
a. RACRC 
b. General outpatient clinic 
c. OAFS 
d. Inter-departmental 
i. Physician 
ii. Surgeon 
iii. Other _______ 
e. Accident & Emergency 
17 Type of referral  
a. Designated referral form(pink form) 
b. Letter  Typed    Hand written  
Symptomatology 
18 Rectal bleeding with CIBH – 6 weeks   All ages Yes  No 
19     Change in Bowel Habits (CIBH)                                            
without rectal bleeding – 6 weeks   >50 yrs  Yes  No 
20 Rectal bleeding without anal symptoms  > 50 yrs Yes  No 
21 Palpable abdominal mass     All ages Yes  No 
22 Palpable rectal mass       Yes  No 
23 Iron deficiency anaemia      Yes  No 
24 Abdominal pain & weight loss     Yes No 
25 Date of diagnosis: 
Appendix II 
 
Investigations 
26 Distant Metastasis 
a. Liver 
b. Lung 
c. Bone 
d. Other 
Histopathology 
27 Synchronous tumour:   Yes No  
28 Anatomical localisation  _________________  
29 Stage A non-A 
30 T Stage 
31 N Stage 
32 M stage 
Operation details 
33 Surgery performed    Yes   No 
34 Resection/surgery   Curative Intent Palliative Intent 
35 Mode of operation    Elective Emergency 
36 Type of operation: 
37 Stoma Yes  No 
38 Stoma Permanent Temporary 
